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ABSTRACT 
IDENTIFYING FUNCTIONAL COMPONENTS OF THE ENDOPLASMIC 
RETICULUM QUALITY CONTROL AND DEGRADATION FACTOR EDEM1 
SEPTEMBER 2018 
LYDIA LAMRIBEN, B.S., NORTHEASTERN UNIVERSITY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Daniel N. Hebert 
 
The ER Degradation-Enhancing Mannosidase-Like protein 1 (EDEM1) is a 
critical endoplasmic reticulum (ER) quality control factor involved in identifying and 
directing non-native proteins to the ER-associated protein degradation (ERAD) pathway. 
However, its recognition and binding properties have remained enigmatic since its 
discovery. Here we provide evidence for an additional redox-sensitive interaction 
between EDEM1 and Z/NHK that requires the presence of the single Cys on the α-1 
antitrypsin ERAD clients. Moreover, this Cys-dependent interaction is necessary when 
the proteins are isolated under stringent detergent conditions, ones in which only strong 
covalent interactions can be sustained. This interaction is inherent to the mannosidase-
like domain (MLD) of EDEM1, for which we demonstrate substrate-binding and glycan-
trimming properties. EDEM1 appears to possess bipartite binding properties as it also 
binds these ERAD variants in a Cys-independent manner under milder detergent 
conditions. In addition, a second intrinsically disordered region (IDR) was identified and 
both are required for machinery interaction, but they are not necessary for Z/NHK 
binding. Interestingly, although the N-terminal IDR is required for binding to another 
ERAD substrate, in this case, neither IDR is required for Z/NHK binding, as the MLD, 
which lacks both IDRs, exhibits glycan-independent and redox-sensitive binding to 
vii 
Z/NHK. Not only is the MLD sufficient to preferentially interact with the α-1 antitrypsin 
ERAD clients, it also possesses, as demonstrated for the first time, catalytic properties as 
observed through glycan-trimming. Although the IDRs do not contribute to Z/NHK 
binding, they are required for binding to the oxidoreductase, ERdj5. These results expand 
our understanding of the range of binding interactions implemented by EDEM1 and help 
elucidate its role as an active mannosidase involved in the quality control machinery of 
the Endoplasmic Reticulum (ERQC). 
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CHAPTER 1 
INTRODUCTION 
(Sections from this chapter are adapted from (Lamriben et al. 2016) 
Protein folding in the endoplasmic reticulum 
Approximately one third of the mammalian proteome is composed of proteins that 
traverse the secretory pathway (Stolz and Wolf, 2010).  These membrane and soluble 
proteins are co-translationally translocated into the endoplasmic reticulum (ER). The 
majority of these proteins undergoes processing as well as acquires covalent modification 
in order to reach their native states. The oxidizing nature of the ER lumen provides a 
suitable environment for proper disulfide bond formation. Additional modifications that 
occur in the ER include signal sequence cleavage, glycosylation, and glycan 
modification. The goal of the quality control (ERQC) machinery in the ER is to 
differentiate between proteins that have reached their native state from those that are 
terminally misfolded.  
Proteins that have successfully folded are released from the folding machinery of 
the ERQC and sorted depending on their target destinations (Dancourt and Barlowe, 
2010; Barlowe and Helenius, 2016). Protein cargo that is destined to reside in other 
organelles or in the extracellular space is packaged into specialized COPII-coated 
vesicles, which exit the ER and transport it to the Golgi as the first step in protein 
trafficking (Barlowe et al., 1994; Belden and Barlowe, 1996; Bi et al., 2007). Once in the 
Golgi, some proteins are further modified and properly folded and assembled cargo is 
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transported out and continues trafficking. Proteins that are improperly folded or 
misassembled are retrieved from the Golgi compartment and returned to the ER. COPI-
coated vesicles carry out this retrograde transport (Hara-Kuge et al., 1994). Proteins that 
are identified as terminally misfolded are extracted from folding attempts and targeted for 
proteasome-dependent degradation through ER-Associated Degradation (ERAD) or 
through autophagy (Figure 1.1). Here, we will focus solely on the events that precede and 
lead to ERAD. For a detailed review on mammalian autophagy please consult the article 
by Bento and colleagues (Bento et al., 2016).  
Secretory protein trafficking begins as nascent secretory polypeptides are targeted 
to the ER through N-terminal signal peptides that are comprised of a large hydrophobic 
domain flanked by an N-terminal basic domain and C-terminal acidic domain (Hegde and 
Bernstein, 2006). Once synthesized and exposed, the signal peptide engages the 
translocation machinery by docking onto the signal peptide recognition particle (SRP), 
which allows it to engage the Sec61 translocation channel (Hegde and Kang, 2008). 
Inside the ER lumen, the nascent polypeptide is modified depending on its ultimate 
topology. For instance, soluble proteins possess cleavable signal peptides, while the 
signal peptide of Type II membrane proteins remains uncleaved and inserts into the ER 
membrane through the hydrophobic domain of the signal peptide.  
The modified luminal polypeptide engages the ERQC machinery once inside the 
lumen. The ERQC is comprised of a network of maturation and quality control factors 
that can be organized into three categories: classical molecular chaperones, redox 
enzymes, and carbohydrate-binding chaperones (Figure 1.1).  
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Classical molecular chaperones 
Classical chaperones recognize exposed hydrophobic surfaces on folding or 
misfolded proteins. The immunoglobulin heavy chain binding protein (BiP) is a member 
of the heat shock protein (Hsp)70 chaperone family and is one of the most abundant 
chaperones in the ER.  BiP is comprised of three domains: an N-terminal nucleotide-
binding domain (NBD); a central substrate-binding domain (SBD); and a C-terminal lid 
domain. The NBD and SBD are connected by a linker (Bukau and Horwich, 1998). The 
chaperone activity of the SBD is regulated by the adenosine diphosphate (ADP) and 
adenosine triphosphate (ATP) bound states of the NBD; wherein an ATP-bound NBD 
yields an open SBD conformation, and an ADP-bound NBD yields a closed SBD with a 
high binding affinity for substrates. BiP associates with a number of cofactors in the J-
domain containing protein family, which when bound to BiP result in ATP hydrolysis.   
 In addition to functioning as a classical chaperone in protein folding, BiP also 
facilitates protein translocation into the lumen through its channel-gating properties on 
the Sec61 complex, and contributes to the activation of the unfolded protein response 
(UPR) in its direct association with the ER stress sensor IRE1α (Haßdenteufel et al., 
2018; Bertolotti et al., 2000).  Additionally, BiP plays a role in ERAD as indicated by 
binding to and promoting the degradation of misfolded ER-retained immunoglobulin 
light chains as well as associating with the J-domain containing cofactors ERdj4 and 
ERdj5, which have both been linked to ERAD (Knittler et al., 1995; Lai et al., 2012; 
Ushioda et al., 2008). 
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Oxidative folding and thiol oxidoreductases 
The oxidative nature of the ER lumen provides an ideal environment for the 
folding of secretory proteins, which unlike other proteins; tend to be richer in cysteine 
(Cys) residues. These Cys are able to undergo oxidation events and form disulfide bonds 
in the ER that they otherwise would not form in the reducing cytoplasm.  These disulfide 
bonds are crucial for the structural integrity and function of many secretory proteins. A 
large portion of secretory proteins possesses intra- or inter-molecular disulfide bonds, 
which facilitate the assembly of multimeric proteins in the ER. To accommodate these 
requirements, the ER has evolved into a specialized organelle for oxidative folding, in 
which pairing of disulfide bonds and correcting improperly paired disulfides, although a 
rate-limiting step, drives protein folding (van den Berg et al., 1999; Matagne and Dobson, 
1998).  
To promote oxidative folding, the ER lumen is equipped with redox components 
such as oxidized glutathione (GSSG) and glutathione (GSH) and approximately 20 
disulfide exchange proteins that belong to the protein disulfide isomerase (PDI) family of 
dithiol-disulfide oxidoreductases (Ellgaard and Ruddock, 2005). The common 
characteristic shared among this protein family is the presence of the conserved 
thioredoxin domain(s), with an active Cys-Xxx-Xxx-Cys (CXXC) site (Ellgaard and 
Ruddock, 2005). These oxidoreductases perform dual functions, as they can either accept 
or donate electrons depending on whether they are forming (oxidation) or breaking 
(reduction) disulfide bonds, respectively. In addition to oxidation and reduction, PDI 
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proteins are also able to shuffle non-native disulfides to obtain native disulfides, in a 
process termed isomerization.  
PDI possesses four thioredoxin-like domains termed a, b, b’ and a’ where only the 
a and a’ domain possess active CXXC motif (Hatahet and Ruddock, 2009). The reduced 
and oxidized structure of human PDI has been solved and revealed that the protein adopts 
a twisted “U” conformation with the active domains a and a’ located at the two ends of 
the structure (Wang et al., 2013; Tian et al., 2006). The catalytically inactive b and b’ 
domains are situated at the center of the structure, or the bottom of the “U”, in a region 
that is highly hydrophobic and proposed to serve as a binding site for misfolded proteins 
and give the protein chaperone-like properties (Tian et al., 2006; Denisov et al., 2009; Cai 
et al., 1994).  
Likewise, the putative substrate-binding cleft that is generated from the twisted 
“U” structures of PDI changes in dimension depending on whether the protein is oxidized 
or reduced, as demonstrated from their respective solved crystal structures (Wang et al., 
2013; Tian et al., 2006). It has been proposed that the size of the cleft created by the open 
(oxidized) versus the closed (reduced) conformation serves to bind substrates that have 
achieved different folding stages, the former being larger, folded polypeptides whose 
disulfides will be formed through an exchange reaction with the active PDI thioredoxin 
site (Oka and Bulleid, 2013). In order to remain catalytically active, PDI undergoes 
constant re-oxidizing events by members of the ER oxidoreductin 1 (Ero1) protein family 
(Frand and Kaiser, 1999; Tu et al., 2000).  
 6 
 
In addition to PDI, the mammalian ER is equipped with other PDI family 
oxidoreductases that function in protein folding or protein degradation. Like PDI, ERp57 
consists of four thioredoxin domains of which the two positioned at each termini, possess 
the active CXXC motifs, while the central thioredoxin folds lack enzymatic activity 
(Ellgaard and Ruddock, 2005). ERp57 associates with the carbohydrate-binding 
chaperones, calnexin and calreticulin in the ER and promotes oxidative folding.  
Another oxidoreductase involved in ERQC is ERp72, which possesses three 
catalytically active domains and two inactive domains (Mazzarella et al., 1990). Although 
the sequence similarity between ERp72 and ERp57 is high, ERp72 does not interact with 
either calnexin or calreticulin, which is likely due to lacking a similar P-domain binding 
patch (Kozlov et al., 2009; Rutkevich et al., 2010). Likewise, mixed disulfides were 
observed between ERp72 and the glycoprotein thyroglobulin, it is unclear how ERp72 
binds these substrates as it lacks any obvious hydrophobic cleft and does not interact with 
lectin chaperones (Menon et al., 2007; Rutkevich et al., 2010).  
The other well-characterized oxidoreductase that contributes to ERQC belongs to 
the HSP40 J-domain containing BiP cofactor family and has been implicated in the 
degradation of misfolded proteins. Of the six J-domain containing proteins identified in 
the ER ERdj5 is the only one to possess a BiP-binding J-domain and thioredoxin 
domains. Structural analyses of ERdj5 revealed an N-terminal J-domain followed by six 
thioredoxin and thioredoxin-like domains labeled in sequential order as Trx1, Trxb1, 
Trxb2, Trx2, Trx3, and Trx4. All of the domains except for Trxb1/ b2 possess reactive 
Cys-Xxx-Xxx-Cys domains (Hagiwara et al., 2011).  
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ERdj5 has been implicated in ERAD as it is able to interact with misfolded 
proteins through BiP, on which it is hypothesized to functions as a reductase to unfold the 
polypeptides and facilitate their extraction from the ER and ultimate destruction (Ushioda 
et al., 2008; Hagiwara et al., 2011). Upon completing its function, ERdj5 was proposed to 
be reduced and returned to its active state by the flavoprotein-associated with degradation 
(ERFAD) (Riemer et al., 2009).  
N-linked glycosylation and the protein folding lectin chaperone network  
The vast majority of mammalian secretory proteins are modified with N-linked 
glycans, which are sugar appendages that are composed of 3 glucoses, 9 mannoses and 2 
N-acteylglucosamines (Glc3Man9GlcNAc2) (Figure 1.2) (Hebert and Molinari, 2007; 
Helenius, 1994). Glycans are covalently attached to the amide side chain of Asn located 
within the N-glycosylation sequence Asn-Xxx-Ser/Thr, where Xxx is any amino acid 
except Pro (Apweiler et al., 1999; Freeze et al., 2014). These glycans are synthesized in 
the ER membrane by a number of cytoplasmic and ER dolichol pyrophosphate lipid 
carrier proteins (Burda and Aebi, 1999). Once synthesized, Glc3Man9GlcNAc2 glycans 
are transferred by the oligosaccharyltransferase (OST) complex en bloc co- and/or post-
translationally to folding glycoproteins. Glycans are bulky amphipathic sugar structures, 
which possess intrinsic properties that promote the solubility of glycoproteins, disfavor 
aggregation, and promote native folding (O’Connor and Imperiali, 1998; Hoffmann and 
Flörke, 1998; Shental-Bechor and Levy, 2008; Jitsuhara et al., 2002).  
N-linked glycans also possess extrinsic properties that allow glycoproteins to 
engage the calnexin/calreticulin folding cycle that constitutes the lectin chaperone 
 8 
 
machinery of the ER, through a series of glycan-trimming events.  The first glycan-
trimming step to occur is deglucosylation. The deglucosylation events in the ER occur in 
a controlled sequential manner which is initiated by α-glucosidase I that cleaves the outer 
most α-1,2-linked glucose (Kornfeld and Kornfeld, 1985) (Figure 1.3). α-glucosidase I is 
a Type-II single pass transmembrane protein with a large globular luminal portion that 
contains the catalytic domain and a short N-terminal cytoplasmic tail (Shailubhai et al., 
1991). α-glucosidase I isolated from mouse fibroblasts was found in a complex with 
Sec61 as observed in proteomics studies of translocon-associated factors, which supports 
early intervention by the enzyme in the protein folding pathway (Dejgaard et al., 2010). 
Once the terminal glucose has been trimmed, the di-glucosylated glycan becomes 
a substrate for α-glucosidase II, a soluble ER resident enzyme that specifically cleaves 
the two α-1,3-linked glucose moieties to generate deglucosylated glycans (Kornfeld and 
Kornfeld, 1985). Human α-glucosidase II is comprised of a large α-subunit (∼100 kDa) 
and a smaller β-subunit (∼50 kDa) that associate non-covalently (Trombetta et al., 1996; 
Stigliano et al., 2011). The α-subunit possesses catalytic activity and is retained in the ER 
by its association with the β-subunit, which possesses an ER retention (KDEL) sequence 
(Pelletier et al., 2000). The β-subunit is not required for the catalytic activity of the 
enzyme; however, it appears necessary for its maturation, solubility and stability. The β-
subunit contains a mannose 6-phosphate receptor homology (MRH) domain, which has 
been proposed to bind the terminal mannose on the trimmed C-branch of glycans, as well 
as the B-branch in order for the enzyme to efficiently act on the A-branch glucoses 
(Munro, 2001; Stigliano et al., 2011). 
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The glycan processing achieved by α-glucosidase I/II results in the transient 
formation of mono-glucosylated glycan, which serves as a substrate for calnexin and 
calreticulin. The type I membrane protein calnexin and its soluble paralog calreticulin 
share a similar general organization. Each is comprised of an N-terminal globular 
domain, a central proline-rich domain and a C-terminal domain. The N-termini of the two 
proteins fold into globular domains consisting of a single carbohydrate-binding site, 
which supports binding specifically to monoglucosylated glycans (Schrag et al., 2001; 
Helenius, 1994). Calcium is important for stabilizing the lectin chaperones and regulating 
their binding to substrates (Li et al., 2001; Brockmeier and Williams, 2006). ATP also 
appears to modulate the conformation of the lectin chaperones, as they become more 
resistant to proteases in its presence, suggestive of their adoption of a more compact 
conformations (Ou et al., 1995; Wijeyesakere et al., 2015).  
Calnexin and calreticulin possess proline-rich domains called P-domains, which 
are the site of interaction with two folding factors: ERp57, a protein disulfide isomerase; 
and cyclophilin B (CyB), a peptidyl prolyl isomerase (Ellgaard and Ruddock, 2005). 
ERp57 contains a P-domain-binding region that localizes it to the vicinity of lectin 
chaperone substrates so it can assist with disulfide bond formation and rearrangement on 
lectin chaperone associated substrates. The interaction between the lectin chaperones and 
ERp57 is transient and occurs in the absence of a client substrate (Frickel et al., 2004; 
Kozlov et al., 2006). The direct association of ERp57 with calnexin and calreticulin has 
been suggested to be important for bringing ERp57 and its substrates together, thereby 
enhancing the local concentration of the isomerase for the catalysis of disulfide bonds. 
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ERp57 knockdown  specifically delays the secretion of glycosylated substrates 
(Rutkevich et al., 2010).   
Calnexin and calreticulin also appear to bind client proteins in a glycan-
independent manner (Danilczyk and Williams, 2001). In vitro studies show that they can 
inhibit the aggregation of non-glycosylated substrates (Saito et al., 1999). The peptide-
binding site is likely located in the vicinity of the glycan binding site within the globular 
domain (Wijeyesakere et al., 2013). While the affinity of calreticulin for glycosylated and 
non-glycosylated substrates appear to be similar, their kinetics is distinct, binding to 
glycosylated clients is more rapid. Glycosylated and non-glycosylated clients support the 
formation of open and closed conformations, respectively, where the closed conformation 
involves the clamping down of the P-domain on the substrate stabilizing substrate 
interactions. The co-factor ERp57 also induces the closed conformation of calreticulin as 
probed using FRET measurements with purified components (Wijeyesakere et al., 2013). 
If a glycoprotein has not reached its native state in a timely manner, it is able to 
re-engage the calnexin/calreticulin folding cycle through a concerted effort by UDP-
glucose glycoprotein glucosyltransferase 1 (UGGT1), which keeps the glycan in a mono-
glucosylated state (Helenius, 1994; Sousa and Parodi, 1995). Once the glycoprotein is in 
a mono-glucosylated state, it also becomes a substrate for α-glucosidase II, which 
competes with UGGT1 with opposing effects (Caramelo and Parodi, 2008). This 
positions UGGT1 as a central gatekeeper in the ER that decides whether glycoproteins 
traffic onto the Golgi and beyond, or are retained in the ER for further assistance.  
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Human UGGT1 is a soluble resident ER enzyme. It possesses a catalytic 
glucosyltransferase domain at its C-terminus. This domain contains a DxD motif that is 
required for its catalytic activity (Tessier et al., 2000; Breton et al., 2006). In an in vitro 
study, purified rat UGGT1 required calcium to transfer glucose onto deglucosylated 
glycoprotein acceptors, suggesting calcium dependence for the catalytic activity of 
UGGT1 (Trombetta and Parodi, 1992). Similar to α-glucosidase II, the catalytic activity 
of UGGT1 is more effective on glycans with high mannose content (Sousa et al., 1992). 
UGGT1 also has a homologue UGGT2 that shares 55% sequence identity with UGGT1 
(Arnold et al., 2000). The C-terminal glucosyltransferase domain appears to be active 
when swapped with the catalytic domain of UGGT1 or when tested in vitro against 
synthetic substrates (Arnold and Kaufman, 2003; Takeda et al., 2014). Currently, no 
biological role has been assigned nor natural substrates of UGGT2 have been identified.  
Mannose trimming direct glycoprotein degradation through ERAD 
Terminally misfolded or irreparably folded glycoproteins are efficiently 
reglucosylated by UGGT1 supporting persistent binding to the lectin chaperones 
(Tannous et al., 2015b). If upon additional rounds of calnexin/calreticulin folding cycles 
the glycoproteins remain misfolded, they are then targeted for destruction (Figure 1.3). 
One way the ERQC machinery is able to distinguish between properly folded proteins 
from aberrantly folded glycoproteins is through the glycan composition they exhibit, or 
glycoform. Specifically, proteins that exhibit extensive demannosylation become poorer 
substrates for calnexin/calreticulin. This is especially true when the A-branch mannoses 
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have been removed resulting in a glycan that can no longer be reglucosylated (Figure 
1.4). 
The process of mannose trimming is suggested to function as a timer mechanism 
in which mannoses are removed slowly and sequentially from the glycans on misfolded 
proteins, reducing the amount of time remaining for the protein to fold with each 
mannose trimming event (Hebert and Molinari, 2012). However, the duration for which 
any given protein is allowed to fold is not a set timeframe and varies for each protein. 
Exactly what causes a protein to be deemed terminally misfolded remains undetermined 
but likely involves bearing a combination of hallmarks of misfolded proteins, such as 
exposing hydrophobic patches, unpaired Cys or mispaired disulfides, and extensive de-
mannosylation.      
Evidence linking de-mannosylation to protein destruction stems from a number of 
early studies into ER degradation. Glycan profiling of terminally misfolded proteins 
revealed extensively trimmed glycoforms (Man7-5GlcNAc2) (Ermonval et al., 2001; 
Frenkel et al., 2003). Experiments in which mannosidase inhibitors such as kifunensine 
(KIF) or 1-deoxymannojirimycin (DMJ) delayed the degradation of terminally misfolded 
substrates (Su et al., 1993). Likewise, exposure of the α1,6-linked mannoses (Figure 1.2), 
which occurs as a result of demannosylation of α1,2-linked mannoses on the B- and C-
branch, may also serve as an protein destruction signal (Clerc et al., 2009; Hosokawa et 
al., 2001; Jakob et al., 2001; Nakatsukasa et al., 2001). Together, these results support the 
presence and function of a single or multiple α1,2 mannosidases in ERQC and ERAD.  
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In mammalian cells, the mannose-trimmed glycans on ERAD targeted 
polypeptides are recognized by the two mannose-6-phosphate receptor homology domain 
(MRH)-containing lectins, Os-9 and XTP3-B (Hosokawa et al., 2009; Cruciat et al., 
2006; Groisman et al., 2011). Yos9p is the yeast OS-9 ortholog (Cormier et al., 2005).  
Thus, Os-9/Yos9p and XTP3-B are proposed to function as ERAD receptors that prepare 
and present the misfolded substrate to the retrotranslocation machinery. Os-9 and Yos9p 
possess a single MRH domain, and Yos9p also possesses a C-terminal ER retrieval and 
retention sequence that is absence in OS-9. Unlike Os-9, XTP3-B possesses two MRH 
domains, although only one is thought to actively bind mannose-trimmed glycans 
(Yamaguchi et al., 2010; Fujimori et al., 2013). 
The role of Os-9/Yos9p in glycoprotein degradation through ERAD has been 
demonstrated through gene deletion studies that resulted in the stability of the misfolded 
mutant variants of carboxypeptidase yscY (CPY*) and α1-antitrypsin Null Hong Kong 
(NHK) (Jaenicke et al., 2011; Christianson et al., 2008; Bernasconi et al., 2008).  
However, no effects were observed for Os-9 on non-glycosylated substrates, although 
Yos9p appears to bind both glycosylated and non-glycosylated substrates (Jaenicke et al., 
2011; Benitez et al., 2011).  The carbohydrate binding affinity of Os-9/Yos9p for ERAD 
glycoforms is stronger than that of XTP3-B (Yamaguchi et al., 2010; Fujimori et al., 
2013).   
Unlike Os-9/Yos9p, the role of XTP3-B in ERAD is less obvious. Some studies 
propose that XTP3-B serves an opposing role to Os-9 and may function as a recognition 
unit for proteins that were accidentally targeted to ERAD, as it appeared to delay the 
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degradation of NHK bearing high mannose glycoforms (Fujimori et al., 2013). XTP3-B 
also interacted with and prevented the degradation of the non-glycosylated ERAD 
substrates transthyretin and NHK (Hosokawa et al., 2008; Christianson et al., 2008). It is 
postulated that XTP3-B prevents the degradation of non-glycosylated substrates by 
interacting with the translocation machinery component Sel1L, thereby delaying their 
degradation and allowing more time for the polypeptides to fold (van der Goot et al., 
2018).  
Os-9/Yos9p and XTP3-B deliver misfolded substrates to the ERAD translocation 
machinery through the mammalian membrane-bound adaptor protein Sel1L or yeast 
adaptor protein Hrd3p (Hampton et al., 1996; Mueller et al., 2006).  Sel1L and Hrd3p 
possess multiple glycans and tetricopeptide repeats (TPRs), both of which mediate 
protein-protein interactions, specifically the C-terminal TPR clusters appear necessary for 
Os9/Yos9p and XTP3-B binding and the glycans are also involved in XTP3-B (Denic et 
al., 2006; Carvalho et al., 2006).  
Once the misfolded substrates are localized to the ERAD retrotranslocation 
machinery they interact with ERAD E3 ligases such as the mammalian Hrd1 and yeast 
Hrd1p, and E2 ligases which tag them for degradation through ubiquitination (Carvalho 
et al., 2006; Christianson et al., 2008; Claessen et al., 2012; Denic et al., 2006; Neutzner 
et al., 2011). The ubiquitin-tagged substrates are dislocated from the ER with the help of 
an AAA-ATPase and once in the cytoplasm the substrates are de-glycosylated and sent to 
the cytoplasmic 26S proteasome (Wolf and Stolz, 2012; Saeki et al., 2009). ER-localized 
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mannosidases are proposed to play a critical role in creating the carbohydrate degradation 
signal that supports recognition by these ERAD receptors. 
Mannosidases and Mannosidase-like proteins of the secretory pathway 
ER resident mannosidases were first discovered from Saccharomyces cerevisiae 
genetic studies and were determined to trim N-linked glycans from Man9GlcNAc2 
structures to Man8GlcNAc2 (Burke et al., 1996). The yeast Mns1p is a Type II ER 
membrane localized alpha1,2-mannosidase involved in glycan trimming and belongs to 
the Class I mannosidase CAZy glycosyl hydrolase (GH family 47 (Henrissat and 
Bairoch, 1996). Proteins belonging to the GH47 family share a conserved (αα)7-
barrel structure and catalytic residues (Karaveg et al., 2005; Mast and Moremen, 2006) 
(Figure 1.5). Mns1p was first implicated in ERAD as its overexpression accelerated the 
degradation of ERAD glycoproteins and its deletion had the opposite effect (Knop et al., 
1996; Jakob et al., 1998, 2001) (Figure 1.5). Mns1p removes the terminal mannose of the 
B-branch, which is believed to be the first step required for generating the glycoforms 
exposing α1,6-linked mannoses that are recognized by Yos9p and targeted for ERAD 
(Figure 1.2) (Jakob et al., 1998). Removing the terminal B-branch mannose also occurs 
on properly folded glycoproteins; however, the mannoses on ERAD bound glycoproteins 
are extensively trimmed in comparison. It is likely that the terminal mannose on the A-
branch of the glycan is removed to prevent re-glucosylation of mature glycoproteins; 
however, the identity of mannosidase responsible for this trimming event is not known.   
A mammalian ortholog of Mns1p was identified and named ER α1,2-mannosidase 
1 or ERman1 (Man1B1) (Figure 1.5). Searches into Man8ClcNAc2 glycan binding lectins 
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in mammalian cells revealed ERman1 as an ideal candidate as it was upregulated upon 
ER stress (Gonzalez et al., 1999). Like Mns1p, overexpression of ERman1 accelerated 
the degradation of the ERAD substrate NHK and glycan analysis of NHK isolated from 
these cells revealed an accumulation of Man8GlcNAc2 (Hosokawa et al., 2001). The 
mannosidase domain of ERman1 was expressed as a soluble recombinant protein and 
exhibited mannosidase activity toward the B-branch of Man9GlcNAc2 glycans. The 
catalytic activity of ERman1 was abolished upon treatment with the mannosidase 
inhibitors kifunensine and 1-deoxymannojirimycin (Tremblay and Herscovics, 1999).   
ERman1 like its yeast ortholog is a type II membrane protein; however, its 
cellular localization is under debate. Golgi co-localization indicate that it may reside in 
the Golgi as an O-glycosylated protein, and its amino acid sequence, although similar to 
the ER localized Mns1p, is homologous to the Golgi α1,2-mannosidases (Tremblay and 
Herscovics, 1999; Pan et al., 2011; Iannotti et al., 2014). Golgi localization of ERman1 is 
further supported from data indicating that it interacts with the protein γ-COPI, a member 
of the Golgi-ER retrograde transport complex, to enhance the degradation of NHK (Pan 
et al., 2013). ERman1 is proposed to interact with γ-COPI to retrieve ERAD substrates 
that evaded the ERQC machinery.  
The mammalian Golgi is equipped with multiple α1,2-mannosidases belonging to 
the Class I GH47 family as well as Class II mannosidases belonging to the GH38 family 
mannosidases; which possesses different catalytic properties (Henrissat, 1991; Moremen 
et al., 1994; Daniel et al., 1994).  The GH47 family Golgi mannosidases is comprised of 
α mannosidase class IA (Man1a1 and Man1a2), class IB (Man1b1 or ERman1) and class 
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IC (Man1c1) (Herscovics, 2001).Man1a1/a2/b1/c1 are type II transmembrane proteins 
that expose a short cytoplasmic facing tail and a conserved Golgi localized mannosidase 
domain, which requires a calcium ion for catalytic activity (Herscovics et al., 1994; Lal et 
al., 1994). Like other members of the GH47 family, the Golgi class 1 α mannosidases are 
inhibited by the inhibitors kifunensine and deoxymannojirimycin (Lal et al., 1994).  
The catalytic activity of mouse Golgi mannosidases was determined using 
purified recombinant proteins and glycan components. These studies revealed that the 
mannosidases exhibit similarities and redundancies in their trimmed glycan products 
although the glycoforms generated and their substrate specificities are not identical 
(Tulsiani and Touster, 1988; Bause et al., 1992; Lal et al., 1998).   
A homolog of Mns1p was also identified in yeast and termed Htm1p (also known 
as Mnl1p) (Jakob et al., 2001) (Figure 1.5). Although Htm1p was originally thought to 
lack mannosidase activity and thus believed to function as a lectin, it was later 
determined to possess hydrolytic activity (Jakob et al., 2001; Quan et al., 2008; Clerc et 
al., 2009; Liu et al., 2016). Specifically, Man8ClcNAc2 glycans are further 
demannosylated by Htm1p on the C-branch, which exposes the ERAD signal α1,6-linked 
mannoses (Quan et al, 2008; Clerc et al., 2009).  
Htm1p mannosidase activity is coupled to its association with the oxidoreductase 
Pdi1p as a mutation on Pdi1p that abolished complex formation between the two proteins 
resulted in less Man7GlcNAc2 glycoforms and delayed the degradation of CPY
*
 (Gauss et 
al., 2011).  Furthermore, Htm1p in complex with Pdi1p is able to distinguish between 
proteins that are misfolded from those that have reached their native folds (Liu et al., 
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2016). This substrate selectivity and mannosidase activity is attributed to a disulfide on 
Htm1p that is introduced by Pdi1p (Sakoh-Nakatogawa et al., 2009).  
The proposed function of EDEM1 and EDEMs in ERAD 
The search and discovery of ERman1 revealed an Htm1p mammalian ortholog, 
the stress-induced mammalian putative mannosidase, ER degradation-enhancing 
mannosidase-like protein 1, or EDEM1 (Hosokawa et al., 2001) (Figure 1.5). Two 
additional ER mannosidase-like proteins are present in the mammalian ER, but are absent 
in the yeast ER, EDEM2 and EDEM3, which share a conserved mannosidase-like domain 
with EDEM1 and are both ER-stress induced and proposed to function in ERAD (Olivari 
et al., 2005; Hirao et al., 2006) (Figure 1.5).  
Although EDEM1 accelerates the degradation of the ERAD substrates and 
misfolded variants of α1-antitrypsin, β-secretase, cystic fibrosis transmembrane 
conductance regulator, rhodopsin and the asialoglycoprotein receptor when 
overexpressed and delay their degradation upon knockdown or knockout, the role of 
EDEM1 in ERAD is not completely understood (Gnann et al., 2004; Hosokawa et al., 
2001; Kosmaoglou et al., 2009; Molinari et al., 2003; Ninagawa et al., 2015; Shenkman 
et al., 2013). For instance, early studies suggested EDEM1 was a catalytically inactive 
mannosidase with lectin-like functions as evidenced by a lack of demannosylation of 
[
3
H]-Man9GlcNAc substrate by EDEM1-IgG immobilized beads (Hosokawa et al., 2001).  
As a lectin, EDEM1 was proposed to recognize misfolded substrates through the 
composition of their glycans, specifically the Man8GlcNAc2 glycoform, and subsequently 
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deliver them to the retrotranslocon (Hosokawa et al., 2010). However, later studies 
showed that EDEM1 promoted glycan trimming on misfolded glycoproteins. 
Overexpression of EDEM1 increased the SDS-PAGE mobility of the ERAD substrates 
NHK and BACE457 compared to when the proposed catalytically inactive EDEM1 
mutant E220Q is overexpressed or in non-transfected cells (Olivari et al., 2006). 
Similarly, Hosokawa and colleagues showed an accumulation of [
3
H]-Man8-6GlcNAc2 in 
cell lysates in which EDEM1 was overexpressed, providing further evidence of 
mannosidase activity (Hosokawa et al., 2010). However, direct evidence that EDEM1 
itself contributes to glycan trimming using purified components is lacking.  
Like EDEM1, EDEM2 was originally thought to lack mannosidase activity as 
EDEM2 isolated from mammalian cell lysates appeared to be inactive (Mast et al., 2005). 
Later it was determined that RNAi silencing of EDEM2 resulted in the accumulation of 
untrimmed glycoforms on ERAD substrates, which implicated a role for EDEM2 in the 
early stages of mannose trimming and labelling terminally misfolded proteins for ERAD 
(Ninagawa et al., 2014).  
Although EDEM2 contributed to glycan demannosylation and generated the Man-
8GlcNAc2 glycoform, which likely results from trimming of the terminal mannose of the 
B-branch in vivo, an in vitro mannosidase assay showed that purified EDEM2 did not 
possess mannosidase activity (Ninagawa et al., 2014; Olivari et al., 2005). This disparity 
could be attributed to the absence of EDEM2 binding partners in the in vitro study. It is 
likely that EDEM2, like Htm1p, requires a binding partner in order to function. 
Furthermore, EDEM2 lacks an ER retention sequence but appears to reside in the ER. It 
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is possible that EDEM2 interacts with ER-resident binding partners in order to remain 
and function in the ER. 
EDEM3 is the largest member of the EDEM protein family, as it possesses an 
uncharacterized region C-terminal of the mannosidase-like domain, which is 
approximately equal in length to the mannosidase-like domain. Structural homology 
analysis predicts a protease-associated (PA) domain of unknown function, which is 
located within this region. The PA domain is predicted to be similar in structure to the PA 
domain of the E3 ubiquitin-protein ligase RNF128 (Anandasabapathy et al., 2003). The 
role of the PA domain in ERAD or other functions has yet to be assessed. 
The KDEL sequence located at the C-terminus of EDEM3 allows its ER retrieval 
and retention. Glycans released from EDEM3 knockout cell lysates were subjected to 
HPLC analysis and were identified as Man8-B glycoforms, indicating that in this 
experiment EDEM3, like EDEM1, acts after the Man8-B glycoform is generated on the 
ERAD substrate (Ninagawa et al., 2014). Thus, EDEM3 is postulated to generate the 
Man8-C glycoform which results in the exposure of α1,6-linked mannose that is required 
for ERAD lectin binding (Ninagawa et al., 2014).  
The substrate binding properties of EDEM1 
The mannosidase-like domain of EDEM1 makes up nearly 70% of the protein; 
however, there is still uncertainty as to whether this domain is required for ERAD of 
misfolded secretory proteins. It is required for interacting with SEL1L, a member of the 
ERAD machinery, as this interaction was abolished upon treatment with the mannosidase 
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inhibitor kifunensine (KIF) and mutation of the putative catalytic residues (Cormier et al., 
2009; Saeed et al., 2011). However, the same study showed that abolishing the putative 
mannosidase activity of EDEM1 or its potential carbohydrate-binding properties did not 
affect the interaction between EDEM1 and the substrate NHK as this association was 
shown to be glycan-independent, indicating that EDEM1 substrate binding and 
machinery binding involves different components (Cormier et al., 2009).  
Similarly, exogenously expressed EDEM1 was shown to associate with and 
accelerate the degradation of other non-glycosylated substrates; a non-glycosylated 
version of H2a, the precursor of asialoglycoprotein receptor, and the non-glycosylated 
protein non-secreted-1 (NS-1) kappa light chain, all of which undergo EDEM1-
dependent degradation (Shenkman et al., 2013). Although these results suggest that the 
substrate-binding properties of EDEM1 reside outside the mannosidase-like domain, 
other data indicate contrary results. For instance, EDEM1 no longer interacted with the 
ERAD substrate BACE457 upon removing its glycans (Molinari et al., 2003).  
EDEM1 was determined to possess an intrinsically disordered region (IDR) 
located at the N-terminus (Marin et al., 2012). EDEM1 lacking its IDR no longer 
associated with a soluble truncation of tyrosinase and surprisingly binding of this N-
terminal truncation to Sel1L was observed; however, its function is unknown (Marin et 
al., 2012). Similarly, an EDEM1 N-terminal truncation that occluded the majority of the 
mannosidase-like domain was sufficient to bind H2a, although at the time this was not 
attributed to the IDR (Shenkman et al., 2013). In addition to the mannosidase-like domain 
and the IDR, it appears that hydrophobic interactions are likely involved in mediating 
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EDEM1-BACE457 binding (Sokołowska et al., 2015). Taken together, these results 
illustrate that the modes of interaction involved between EDEM1 and either ERAD 
substrates or ERQC machinery is specific to each protein’s requirements. 
Conclusions 
 Although much is known about the key players and major events involved in 
ERAD and ERQC many details remain elusive to this day. The connection between 
ERAD and glycan-trimming is clear, however the role of each mannosidase, which in 
many cases appears overlapping is less so. EDEM1 is an enigmatic protein and efforts to 
determine whether EDEM1 truly possesses catalytic activity have been hindered by the 
presence of numerous ER and Golgi α1,2-mannosidases and by the inability to isolate 
and purify EDEM1 for downstream in vitro biochemical analyses. Likewise, difficulties 
in determining the binding properties of EDEM1 is compounded by the fact that multiple 
modes of interactions are employed and each appear binding partner- and ERAD 
substrate-specific. EDEM1 has to be fully characterized before we can address its true 
role in ERAD and ERQC.  
 The present work examines novel EDEM1 substrate-binding requirements that 
were identified in cells using lysis detergents of varying strengths. EDEM1 exhibited 
bipartite binding properties toward the same substrate, NHK, depending on the detergent 
strength. A redox-sensitive binding interaction was identified from this study and 
required the presence of a Cys residue on NHK. Additionally, the EDEM1 mannosidase-
like domain was successfully expressed in cells and its in vivo properties were 
characterized and it was determined to promote glycan trimming and the redox sensitivity 
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binding property was maintained. Since the mannosidase like domain is functional, 
purifying it alone will be a powerful tool to properly study the in vitro enzymatic 
properties of EDEM1. Lastly, a second IDR was identified on EDEM1 and contributed to 
its rapid turnover. Both IDRs are involved in mediating the EDEM1-ERdj5 interaction.  
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Figure 1.1 Secretory protein trafficking 
Secretory polypeptides are co-translationally translocated into the ribosome-studded 
endoplasmic reticulum (Rough ER). Once inside the ER lumen, the polypeptides engage 
the ER quality control (ERQC) machinery, which is composed of molecular chaperones 
(green), redox enzymes (yellow), and glycan modifying enzymes (purple).  The ERQC 
assists in protein folding and possess the ability to differentiate between mature, properly 
folded proteins (black cube) from terminally misfolded proteins (red). The mature 
proteins are allowed to exit the ER through vesicles of the smooth ER and are transported 
to the Golgi where they acquire further modifications that include additional assembly 
processes, and glycan modification. The mature proteins are then sorted to their final 
destination. Proteins that are terminally misfolded (red) are extracted from futile folding 
cycles and targeted for degradation by the proteasome.  
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Figure 1.2 Structure 
of N-linked glycan 
N-linked glycans are transferred en bloc to asparagine residues in the sequon Asn-X-
Ser/Thr, where X denotes any amino acid except for Pro. The precursor structure is 
composed of three glucoses (blue circles), nine mannoses (green circles) and two N-
acetylglucosamines (blue squares). Glycosidic bonds are noted. (Lamriben et al., 2016) 
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Figure 1.3 Processing of N-linked glycans and folding pathway of secretory 
glycoproteins in the Endoplasmic Reticulum 
N-linked glycans, assembled by Alg gene protein products (1), are transferred via the 
OST complex to proteins translocated into the ER lumen (2). Glucosidases I and II trim 
the first two glucoses (blue circles) from the glycan (3), generating a monoglucosylated 
glycoform, which is a substrate for calnexin (CNX) and calreticulin (CRT) (4). Trimming 
of the remaining glucose by glucosidase II releases the substrate from CNX/CRT (5). 
Glycoproteins that do not reach their native folded state can be reglucosylated by UGGT1 
(6), redirecting them to CNX/CRT binding (7) or trimming by glucosidase II (8). 
Glycoproteins that have reached their native state (star) (9) are trimmed by mannosidases 
and directed for trafficking out of the ER (10). Proteins that are terminally misfolded are 
trimmed by mannosidases and directed for ERAD (11). (Lamriben et al., 2016) 
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Figure 1.4 Glycoforms of the endoplasmic reticulum 
N-linked glycans are processed in the ER through many trimming events that remove 
glucoses or mannoses depending on the processing enzyme. N-linked glycans exhibiting 
glucoses (blue circles) are found on newly synthesized polypeptides or on proteins that 
are undergoing folding. High mannose (green circles) content glycans consisting of 9-7 
mannoses are present on mature proteins. Glycans possessing fewer mannoses (7 or less) 
are typically found on misfolded, ERAD targeted substrates.   
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Figure 1.5 GH47 family proteins members of the yeast and mammalian ER 
The solved and predicted structures of selected Glycosylhydrolase 47 Family Protein 
domains. Structural predictions of the Htm1p and EDEM1-3 mannosidase-like domains 
were generated through the PHYRE2 Protein Fold Recognition Server. The conserved 
putative mannosidase acidic residues located at the core of the (αα)7-barrel structure are 
labeled in red. Cysteines that are in close proximity and may form disulfide linkages are 
labeled in magenta. Cysteines that appear free are labeled in yellow and those that exist 
as a Cys-X-X-Cys motif are labeled in green.  
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CHAPTER 2 
METHODS AND EXPERIMENTAL PROCEDURES 
Reagents 
Dulbecco’s modified Eagle’s medium (DMEM) minimum essential media alpha 
(αMEM), fetal bovine serum (FBS), penicillin and streptomycin (P/S) were purchased 
from Invitrogen.  Endo H, PNGase F, and all cloning reagents were acquired from New 
England Biolabs. Human embryonic kidney (HEK) 293 cells were purchased from ATCC 
(Lot#: 6322631) and HEK293A from Invitrogen (Lot#1806222). Cells were 
authenticated by universal mycoplasma detection kit (Cat. No. 30-1012K, ATCC). [
35
S]-
Met/Cys was acquired from PerkinElmer. Protein A Sepharose 4B was from GE 
Healthcare. Methoxypolyethelene glycol maleimide was purchased from Sigma-Aldrich 
(Cat. No. 63187). The following antibodies were used: αFLAG (Cat. No. F3165, Sigma), 
αA1AT (Cat. No. A0012, Dako), αMYC (Cat. No. 9B11, Cell Signaling), and 
αGlucosidase II (Cat. No. PA5-21431, Thermo Fisher). The following C-terminally 
tagged EDEM1 truncations were generated by PCR amplification and subcloned into 
p3XFLAG-CMV-14 (Addgene): EDEM1 IDR-ΔN (Δ48-119), EDEM1 IDR-ΔC (Δ 583-
652), and EDEM1 MLD (Δ48-119 and Δ 583-652). EDEM3-MYCFLAG was purchased 
from Origene Technologies (Cat. No. RC222885).  Transfections were carried out with 
polyethyleneimine “MAX” (PEI) (Cat. No. 24765, Polysciences, Inc.).  
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Cell culture and Transfections  
HEK293T, HEK293A and CHO (KO man1a1/1a2/1b1/1c1) cell were cultured in 
DMEM (for HEK) and αMEM supplemented with 10% (FBS) and 100 U/ml penicillin 
and 100 mg/ml streptomycin at 37
o
C in 5% CO2. Transfections were carried out using 
PEI at a ratio of 1:3 (PEI (ug): DNA (ug)) for all transient transfections except in the 
immunofluorescent microscopy assay for which Lipofectamin 2000 was used at a 1:2 
ratio (Lipofectamine (ug): DNA (ug)). 
Protein Radiolabeling and pulse chase analysis  
HEK293 or CHO (KO man1a1/1a2/1b1/1c1) cells were grown in 35 or 60 mm 
dishes where indicated and all transfections were carried out for 18 h in DMEM (or 
MEM for CHO cells) supplemented with 10% FBS and 1% P/S and incubated at 37
o
C in 
5% CO2. Cells were lysed on ice with either CHAPS buffer (2% 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate in 50 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid and 200 mM NaCl, pH 7.5 (HBS)), or with MNT buffer 
(0.5% Triton X-100, 20mM MES, 100 mM NaCl, 20 mM Tris-HCl (pH 7.5)). The post-
nuclear supernatant was isolated by centrifugation followed by pre-clearing with unbound 
protein-A Sepharose beads, and subsequent incubation with the corresponding antibody 
and Sepharose beads overnight. Immunopellets were isolated and washed with 0.5% 
CHAPS in HBS or Connie’s wash buffer (100 mM Tris-HCl, 300 mM NaCl, 0.1% SDS, 
0.05% Triton X-100 (pH 8.6)) where indicated. Proteins were eluted from beads with 
reducing sample buffer, followed by SDS-PAGE. Radiolabled samples were visualized 
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using phosphorimaging (FLA-500; Fujifilm) and quantified using ImageQuant TL 1D gel 
analysis software (GE Healthcare Life Science).  
Sequential immunoprecipitation 
Immunopellets were washed with 0.5% CHAPS in HBS or Connie’s wash buffer 
(100 mM Tris-HCl, 300 mM NaCl, 0.1% SDS, 0.05% Triton X-100 (pH 8.6)) and eluted 
from beads with reducing sample buffer. When followed by a second 
immunoprecipitation, samples were eluted with 1% SDS in 10 mM Tris, pH 7.5, and 150 
mM NaCl at 100°C and quenched with excess 2% CHAPS in HBS, followed by 
incubation with the corresponding antibody and Sepharose beads overnight and washing 
with 0.5% CHAPS in HBS or Connie’s wash buffer where indicated. 
In vivo reactive thiol analysis  
HEK293T cells were transfected with EDEM1 constructs and incubated 
overnight. The next day (~20 h later), a subset of the samples were pretreated with 5 mM 
DTT for 1 hr. Cells were lysed with sample buffer (30 mM Tris pH 6.8, 9% SDS, 15% 
glycerol) containing 5 mM Peg maleimide or 20 mM NEM. Lysates were incubated for 1 
hr. Step-by-step protocol is published in Current Protocols Protein Science (Braakman et 
al., 2017). 
Immunoblotting and imaging 
HEK293T cells were grown in 35 or 60 mm dishes and all transfections were 
carried out for 18 h in DMEM supplemented with 10% FBS and 1% P/S and incubated at 
37
o
C in 5% CO2. Cells were lysed on ice with either CHAPS buffer (2% 3-[(3-
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cholamidopropyl) dimethylammonio]-1-propanesulfonate in 50 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid and 200 mM NaCl, pH 7.5 (HBS)), or with MNT buffer 
(0.5% Triton X-100, 20mM MES, 100 mM NaCl, 20 mM Tris-HCl (pH 7.5)). The post-
nuclear supernatant (PNS) was isolated by centrifugation followed by pre-clearing with 
unbound protein-A Sepharose beads, and subsequent incubation with the corresponding 
antibody and Sepharose beads overnight. A fraction of the PNS (10%) was treated with 
10% trichloroacetic acid to collect the whole cell lysate, where indicated.  Immunopellets 
were isolated and washed with 0.5% CHAPS in HBS or Connie’s wash buffer (100 mM 
Tris-HCl, 300 mM NaCl, 0.1% SDS, 0.05% Triton X-100 (pH 8.6)), where indicated. 
Proteins were either subjected to glycosidase digestion (following New England Biolabs 
protocol) (where indicated) or eluted from beads with reducing sample buffer, followed 
by SDS-PAGE. Proteins were transferred onto nitrocellulose membrane (LI-COR, Inc.) 
and blocked in 1X PBS containing 5% Milk and 2% bovine serum albumin. Membranes 
were blocked overnight at 4
o
C, followed by an over night incubation with primary 
antibody at 4
o
C. LI-COR IRDye fluorescent secondary antibodies were used for detection 
at 1:10,000 dilution. Blots were imaged and analyzed using the Odyssey Sa imaging 
system (LI-COR, Inc).  
CRISPR/Cas9 targeted KO man1a1/1a2/1b1/1c1 in CHO cells.  
Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated 
protein 9 (CRISPR/Cas9) system was used for gene knockout (KO) in CHO cells as 
described preciously (Schulz et al., 2018). CHOZN GS
-/- 
cells with stable expression of 
human alpha-galactosidase A were used as parental clone for KO man1a1/1a2/1b1/1c1. 
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Cells were maintained as suspension cultures in EX-CELL CHO CD Fusion serum-free 
media (Cat. No. 14365C, Sigma) in 50 mL TPP TubeSpin® and incubated at 37°C and 
5% CO2. Cells were seeded at 0.5 × 10
6
 cells/mL in T25 flask (NUNC, Denmark) one 
day prior to transfection. Electroporation was conducted with 2x10
6
 cells with a DNA 
mixture of 1 μg of Cas9-GFP plasmid and 1μg of gRNA plasmid (U6GRNA, Addgene 
Plasmid #68370) using Amaxa kit V and program U24 with Amaxa Nucleofector 2B 
(Lonza, Switzerland). 48 hrs after nucleofection the 10-15% highest GFP expression pool 
of cells were enriched by FACS, and after 1 week cultured cells were single cell sorted 
by FACS into 96-wells. Gene disruption was identified by Indel Detection by Amplicon 
Analysis (IDAA) as described (Yang et al., 2015) and was further verified by Sanger 
sequencing 
Immunofluorescent microscopy 
HEK293A cells were transfected with indicated EDEM1 constructs and incubated 
for 24 hr at 37
o
C and 5% CO2. Transfected cells were fixed with 3.7% paraformaldehyde 
in 1X phosphate-buffered saline (PBS) for 15 min at room temperature followed by 
permeabilization with 0.1% Triton X-100 in 1X PBS for 30 min at room temperature. 
Slides were rinsed in 1X PBS followed by blocking with 10% fetal bovine serum in 1X 
PBS for 30 min at room temperature. Cells were rinsed and stained with the indicated 
primary antibody solution at a 1:200 dilution factor followed by staining with the 
respective Alexa Fluor 488 or 594 secondary antibodies at a 1:400 dilution factor in 
blocking buffer. Cells were rinsed and mounted onto coverslips pretreated with 
VectaShield (Vector Laboratories). Images were acquired using A1
+
/A1R
+
 confocal 
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microscope (Nikon). The microscopy data was gathered in the Light Microscopy Facility 
and Nikon Center of Excellence at the Institute for Applied Life Sciences, UMass 
Amherst with support from the Massachusetts Life Science Center. 
Sucrose gradient centrifugation 
HEK293T cells were transfected with EDEM1 MLD and incubated for 48 hr. 
DTT was added to appropriate samples at (5 mM) for 1 hr prior to lysis in MNT buffer. 
The post-nuclear supernatant was layered atop a continuous 10-40% sucrose gradient in 
MNT buffer. The gradients were centrifuged for 18 hr at 4 °C with a Beckman SW41 at 
38,000 rpm. After centrifugation, 8.5% of total gradient volume was collected per 
fraction, and proteins were isolated by trichloroacetic acid precipitation. Samples were 
resuspended in reducing sample buffer and analyzed by immunoblotting with the anti-
FLAG antisera. The pellet was processed by adding sample buffer directly to the 
ultracentrifugation tube, after the last fraction was collected. 
Alkaline extraction 
Alkaline extraction was performed as previously described (Tamura et al., 2011). 
HEK293T cells expressing EDEM1 and IDR constructs were resuspended in 
homogenization buffer (20 mM HEPES, pH 7.5, 5 mM KCl, 120 mM NaCl, 1 mM 
EDTA, and 0.3 M sucrose) on ice and passed through a 22-gauge needle 20 times. All 
subsequent steps were conducted at 4 0C. The homogenate was centrifuged at 1,000 g for 
10 min to pellet the nuclear fraction. The post nuclear fraction was centrifuged for 10 min 
at 45,000 rpm in a Beckman rotor (TLA 120.2) to separate the cytosol (supernatant) from 
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the cellular membranes (pellet). The cellular membrane fraction was resuspended in 
homogenization buffer, and a portion of the resuspended membranes was incubated with 
0.1M Na2CO3 (pH 11.5) for 30 min on ice. The alkaline extracted portion was 
centrifuged at 65,000 rpm for 20 min through a sucrose cushion (50 mM triethanolamine, 
0.3 M sucrose, pH 7.5) to separate soluble proteins from membrane proteins in the 
supernatant and pellet, respectively. The pH was adjusted in the alkaline extracted sample 
with 1M Tris-HCl (pH 7.5). Proteins were isolated by trichloroacetic acid precipitation. 
Samples were resuspended in reducing sample buffer and analyzed by immunoblotting 
with the anti-FLAG antisera  
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CHAPTER 3 
EDEM1 MANNOSIDASE-LIKE DOMAIN BINDS ERAD CLIENTS IN A 
REDOX-SENSITIVE MANNER AND POSSESSES CATALYTIC ACTIVITY 
Abstract 
The endoplasmic reticulum (ER) degradation-enhancing α-mannosidase-like 1 
protein (EDEM1) is a quality control factor that was initially proposed to recognize N-
linked glycans on misfolded proteins through its mannosidase-like domain (MLD). 
However, recent studies have demonstrated that EDEM1 binds to some misfolded 
proteins in a glycan-independent manner. In this study, we have identified a thiol-
dependent substrate interaction between EDEM1 and the α-1 Antitrypsin ERAD clients, 
Z and NHK, specifically though the single Cys residue on Z/NHK (Cys256), under 
stringent detergent conditions. In addition to the thiol-dependent interaction, the presence 
of weaker protein-protein interactions was confirmed, suggestive of bipartite client 
binding properties. Reactive thiols on EDEM1 (~4) were identified and are not directly 
responsible for the observed EDEM1 redox-sensitive binding. Moreover, a construct 
comprised of the EDEM1 MLD was expressed and its thiol-dependent binding properties 
were observed along with its active glycan-trimming properties. Lastly, an additional 
intrinsically disordered region (IDR) located at the C-terminus of EDEM1 was identified 
in addition to the previously identified N-terminal IDR and it was determined that either 
IDR is required for binding to ERdj5 as an interaction with ERdj5 was not recovered with 
the MLD alone. Together, our findings indicate that EDEM1 employs different binding 
modalities to interact with ERAD clients and ER quality control (ERQC) machinery 
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machinery partners and some of these properties are shared with its homologues EDEM2 
and EDEM3. 
Introduction 
In the ER lumen, nascent polypeptides gain access to an array of molecular 
chaperones and foldases such as BiP, lectin molecular chaperones such as calnexin 
(CNX) and calreticulin (CRT), and oxidoreductases like PDI and ERp57, all of which 
comprise part of the ERQC machinery (Appenzeller-Herzog and Ellgaard, 2008; 
Lamriben et al., 2016; Parodi et al., 2015; Tannous et al., 2015b). The ERQC attempts to 
fold and rescue aberrantly folded proteins by protecting exposed hydrophobic regions 
(BiP), binding to N-linked glycans (CNX and CRT), and catalyzing the formation of the 
correct disulfide bonds (PDI, ERp57 etc.). 
Terminally misfolded proteins are extracted from futile folding cycles, prevented 
from re-engaging the ERQC machinery and ultimately targeted for degradation via the 
ER-Associated Degradation (ERAD) pathway (Nakatsukasa and Brodsky, 2008; Hebert 
and Molinari, 2007). Numerous ERAD components have previously been characterized 
that recognize exposed hydrophobic regions, mispaired disulfide bonds, or specific N-
linked glycan structures. For instance, mannosidases contribute to the extensive glycan 
trimming that occurs on ERAD-bound clients, and oxidoreductases are proposed to 
facilitate retrotranslocation by unfolding and reducing ERAD clients to make them 
translocation competent (Ermonval et al., 2001; Frenkel et al., 2003; Ushioda et al., 
2008).  
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The ER Degradation Enhancing Mannosidase-Like protein-1 (EDEM1) has been 
proposed to select and sequester terminally misfolded proteins away from productive 
folding cycles and target them for degradation as evidenced by its preferential interaction 
with misfolded ERAD clients, direct interaction with ERAD machinery components such 
as Sel1L and ERdj5, and acceleration of the degradation of misfolded clients when 
overexpressed (Cormier et al., 2009; Hosokawa et al., 2001; Molinari et al., 2003; Oda et 
al., 2003; Kosmaoglou et al., 2009). 
Although EDEM1 and its role in ERAD has been extensively studied and 
characterized since its discovery in 2001 (Hosokawa et al., 2001; Oda et al., 2003), much 
of the protein’s properties remain enigmatic. For instance, early EDEM1 studies 
suggested that EDEM1 lacked mannosidase activity although it shares a mannosidase-
like domain similar to that of the active ER mannosidase, Man1b1 (ER ManI) (Hosokawa 
et al., 2001). However, several groups have demonstrated contradictory cellular findings 
showing EDEM1 has weak mannosidase activity (Hosokawa et al., 2010; Ninagawa et 
al., 2014; Olivari et al., 2006). Additionally, attempts to ascertain on which glycan branch 
EDEM1 acts have been conducted by determining the glycan profile of cells in which 
EDEM1 was overexpressed or knocked out, but in vitro analyses using recombinant 
EDEM1 or its MLD are lacking, likely due to difficulty in expressing recombinant 
EDEM1 and its MLD (Ninagawa et al., 2015, 2014). 
EDEM1 has been implicated to play a role in ERAD and function in the ER 
lumen; however, how the protein is retained in the ER lumen remains undetermined. 
EDEM1 exhibits dual topology as a result of inefficient cleavage of its signal peptide, 
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which yields a membrane-bound protein that is able to act on membrane-associated 
ERAD clients (Tamura et al., 2011). However, EDEM1 also exists as a soluble luminal 
protein that remains in the ER while lacking a known ER retention/retrieval sequence. 
EDEM1 interacts with numerous ER-localized binding partners and is proposed to exist 
in a multiprotein complex; which may mediate its ER retention, although this has yet to 
be shown.  
The client- or machinery-binding properties of EDEM1 appear multifaceted and 
specific to each binding-partner. For instance, the Lederkremer group showed that N-
terminal truncation of EDEM1 possessing a portion of the MLD is sufficient for binding 
to H2a (Shenkman et al., 2013). Petrescu and colleagues identified an N-terminal IDR 
that is required for interaction with a unnatural soluble form of tyrosinase, further 
supporting the nonessential role of the MLD in the interaction between EDEM1 and H2a 
or soluble tyrosinase (Marin et al., 2012). Likewise, the role of glycans in EDEM1 client 
binding is perplexing and appears substrate-specific, as in some cases (NHK, H2a, and 
SHH) interactions with EDEM1 were independent of substrate glycosylation; however, in 
other cases glycans appeared required (BACE457) (Cormier et al., 2009; Molinari et al., 
2003; Shenkman et al., 2013; Tang et al., 2014). Interactions between EDEM1 and ER 
machinery binding partners have been reported and characterized, most notably being 
that the EDEM1 MLD was involved in the interaction with Sel1L, as mutating the 
putative catalytic triad or using mannosidase inhibitors abolished this interaction 
(Cormier et al., 2009; Saeed et al., 2011). 
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Combined, these results illustrate a much more complex binding landscape of 
EDEM1 that involves distinct protein-dependent modes of interactions. In this study, we 
have identified bimodal interactions between EDEM1 and the α1-antitrypsin (A1AT) 
disease-associated and ERAD variants Z and NHK. The interactions between EDEM1 
and Z/NHK involve covalent and weaker protein-protein interactions that were identified 
under different detergent conditions. We also provided evidence that the MLD of 
EDEM1 possesses glycosidase activity.  Altogether, these findings broaden the scope of 
the EDEM substrate-binding properties and provide further evidence supporting cellular 
mannosidase activity of the EDEM1 MLD.   
Results 
The binding of EDEM1 to misfolded A1AT is bipartite and involves oxidation-
dependent and weak protein-protein interactions 
EDEM1 preferentially interacts with misfolded A1AT variants NHK and Z in a 
glycan-independent manner (Cormier et al., 2009). Given the oxidative nature of the ER 
lumen, we determined whether this preferential interaction is oxidation-dependent. A 
pulse-chase experiment was performed to compare the protein interactions in the absence 
or presence of the reducing agent dithiothreitol (DTT) (Figure 3.1). EDEM1-FLAG was 
co-expressed in HEK293T cells with wild type (WT) A1AT, Z or NHK. The proteins 
were radiolabeled for 30 min, followed by a 15-min chase, to allow EDEM1 to reach its 
mature folded state. A 30-min chase with or without 5 mM DTT was performed (+/- 
lanes) following the initial 15 min chase (Figure 3.1).  Cells were lysed with 0.5% Triton 
X-100 in MNT buffer (TX) or with 2% 3-[(3-cholamidopropyl)dimethylammonio]-1-
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propanesulfonate (CHAPS or CH) in HBS. Cell lysates were divided into equal fractions 
and subjected to anti-A1AT (Figure 3.1, lanes 1-12) and anti-FLAG (Figure 3.1, lanes 
13-24) immunoprecipitations. Immunoprecipitations obtained from “TX” lysates were 
washed under stringent buffer conditions containing 0.1% SDS while those obtained from 
“CH” lysates were washed under milder conditions using 0.5% CHAPS.  
The DTT treatment did not affect the maturation or secretion of WT A1AT as the 
protein appears to have reached its mature state as indicated by the presence of complex 
sugars acquired in the Golgi as demonstrated by the higher molecular weight species 
(Figure 3.1, lanes 1-4). Additionally, the DTT treatment did not appear to affect the 
inherent binding properties of EDEM1 as it did not bind to WT A1AT regardless of the 
of the addition of DTT using either TX/SDS or CHAPS washes (Figure 3.Figure 3.1, 
lanes 1-4 and 13-16).  
Under mild detergent conditions (CHAPS), the interaction between EDEM1 and 
NHK (Figure 3.Figure 3.1, lanes 5, 6, 17, and 18) or Z (Figure 3.Figure 3.1, lanes 9, 10, 
21, and 22) was maintained regardless of the whether DTT was added. However, under 
stringent detergent conditions (TX/SDS), the interaction between EDEM1 and NHK 
(Figure 3.Figure 3.1, lanes 7, 8, 19, and 20) or Z (Figure 3.Figure 3.1, lanes 11, 12, 23, 
and 24) was disrupted upon addition of DTT indicating the presence of an oxidation 
requirement, as well as the involvement of weaker protein-protein interactions.  
WT A1AT and the misfolded variants NHK and Z possess a single cysteine (Cys 
or C) residue at position 256 and three N-linked glycosylation sites (Figure 3.Figure 
3.2A). We have previously determined that the interaction between EDEM1 and NHK is 
 43 
 
glycan-independent under stringent detergent conditions (Cormier et al., 2009). Next, 
A1AT Cys256 was determined as a possible mediator of the interaction between A1AT 
and EDEM1.  
Cys256Ser mutants of Z and NHK were generated and tested for their binding to 
EDEM1 (Figure 3.Figure 3.2B). EDEM1-FLAG was co-expressed in HEK293T cells 
with WT A1AT, Z, Z C256S, NHK, or NHK C256S. The proteins were radiolabeled for 
30 min, followed by 1 hr chase. Cells were lysed in MNT buffer and washed in buffer 
containing 0.1% SDS. EDEM1 no longer interacted with Z or NHK when the Cys was 
mutated to a Ser (Figure 3.Figure 3.2B, lanes 21-24), suggesting that the previously 
observed covalent-like interaction between the misfolded A1AT ERAD variants and 
EDEM1, involved the single Cys256 from A1AT. 
EDEM1-FLAG possesses multiple reactive maleimide-modifiable Cys  
To determine whether the interaction between EDEM1 and NHK or Z involves 
reactive thiols or unpaired Cys on EDEM1, we conducted an in cell maleimide 
modification assay using mehtoxypolyethelene glycol maleimide (PEG-Maleimide) 
(Figure 3.Figure 3.3A). HEK293T cells were transfected with EDEM1-FLAG and a 1 hr 
DTT pre-treatment was added to designated dishes. Cells were lysed in sample buffer 
containing 5 mM PEG-Maleimide (+ PEG-Maleimide) or 20 mM NEM (- PEG-
Maleimide) to modify reactive thiols (Figure 3.Figure 3.3B).  
Human EDEM1 possesses eight Cys residues that are well conserved across 
metazoan species (Figure 3.Figure 3.3C). All eight Cys were modified upon treatment 
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with PEG-maleimide following DTT-pretreatment (Figure 3.Figure 3.3B, compare 
mobility shift between lanes 3 and 4). However, under oxidizing conditions (- DTT 
pretreatment), approximately half of the Cys were accessible to maleimide modification 
(Figure 3.Figure 3.3B, compare lane 2 to lane 1, 3 and 4) as the modified protein migrates 
slower than the unmodified but faster than the fully modified sample, indicating that a 
subset of the Cys on EDEM1 was accessible and reactive at steady state.  
The oxidized and maleimide-modified sample (Figure 3.Figure 3.3B, lane 2) was 
compared to series of EDEM1 constructs on which a single Cys to Ser mutation was 
generated in order to obtain EDEM1 comprised of 7, 6, 5, and 4 total Cys residues 
(Figure 3.Figure 3.3D). The number of accessible and reactive Cys on EDEM1 under 
oxidizing conditions can be estimated as four, as the protein migrates at approximately 
the same level as EDEM1 4Cys on SDS-PAGE (Figure 3.Figure 3.3D, compare lane 2 to 
lane 3).  
Furthermore, modeling of the conserved EDEM1 MLD predicts that four of the 
Cys are in sufficient proximity to form two disulfide bonds (Cys160-Cys529 and Cys410-
Cys457) (Figure 3.Figure 3.3E, left panel). The two remaining Cys in the MLD (Cys302 
and Cys555) might act as free thiols. There are two additional Cys found outside the 
predicted mannosidase domain, one N-terminal and the other C-terminal, which could 
pair up with each other, or with Cys302 or Cys555, or remain free thiols. This 
information was used to derive a predicted disulfide map of EDEM1 (Figure 3.Figure 
3.3E, right panel).  
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We next sought to identify the reactive thiols at steady state, using the maleimide 
modification assay and monitoring the mobility shifts of each sample under oxidizing 
conditions compared to that of WT EDEM1 (Figure 3.4A). Combinational Cys to Ser 
mutants of the predicted reactive Cys (C95/302S, C555/629S, C95/302/629S, and 
C95/302/555/629S) were generated and transfected in HEK293T cells. Proteins were 
subjected to PEG-maleimide modification under reducing (+ DTT pretreatment) and non-
reducing (- DTT pretreatment) conditions. Proteins were resolved on SDS-PAGE and 
subjected to immunoblotting.  
The resulting blots were positioned such that the reduced protein samples in each 
condition were aligned (Figure 3.4A, lanes 1, 2, 5, 7, 9, 10, 13, 15, 17, and 19). The 
mobility shifts of the oxidized and maleimide-labeled combinational mutants C95/302S 
and C95/302/629S were compared to WT EDEM1 (Figure 3.4A, compare lanes 6 and 14 
to lane 3) and in both instances the proteins migrated faster through the gel, with the 
triple mutant migrating the fastest, indicating that these constructs possess fewer 
accessible thiols than the WT protein, likely two and one, respectively.  
The same analysis was performed with constructs in which C555 was mutated to 
Ser (C555/629S and C95/302/555/629S); however, both mutations resulted in a smear 
when labeled with PEG-maleimide under oxidizing conditions (Figure 3.4A, lanes 11 and 
18). The same result was obtained with the single C555S point mutant (data not shown), 
which may implicate Cys555 in forming transient intermediate disulfides, perhaps as the 
resolving Cys residue, which when mutated to a Ser results in mixed disulfide species.   
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The interaction between EDEM1 comprising single Cys to Ser mutations and 
NHK was maintained under stringent detergent conditions (Figure 3.4B), indicating that a 
single EDEM1 Cys residue was not solely responsible for maintaining the interaction. 
We then determined whether the reactive thiols contributed to the thiol-dependent 
interaction that was observed under stringent detergent conditions. To this end, WT 
EDEM1-FLAG, C95/302/629S, and C95/302/555/629S were co-expressed with A1AT 
WT, Z and NHK (Figure 3.4C).   
The EDEM1-FLAG C95/302/629S, and C95/302/555/629S construct both co-
immunoprecipitated with Z and NHK as observed by the presence of EDEM1-FLAG 
protein (Figure 3.4A, lanes 5, 6, 8 and 9, compared to WT in lanes 1, 4 and 7) with the 
anti-A1AT immunoprecipitation. These interactions were verified using anti-FLAG 
immunoprecipitations where the presence of Z and NHK was observed with the EDEM1 
pull-downs (Figure 3.4A, lanes 11, 12, 14, 15, 17 and 18, compared to WT in lanes 10, 
13 and 16).   
Similar to the WT EDEM1, EDEM1-FLAG C95/302/629S, and 
C95/302/555/629S exhibit preferential interaction with ERAD clients, as neither protein 
interact with ATAT WT (Figure 3.4A, lanes 10, 13, and 16). Taken together, EDEM1-
FLAG possesses multiple reactive thiols, as Cys at positions 95, 302, 555, and 629 appear 
unpaired and accessible to maleimide modification at steady state; however, these 
residues do not appear to mediate the thiol-dependent interaction that was observed 
between EDEM1 and NHK/Z. 
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Identification of EDEM1 IDRs 
Previous studies by Petrescu and colleagues have identified an IDR at the N-
terminus of EDEM1 that was required for soluble tyrosinase binding (Marin et al., 2012). 
To address whether other IDRs are present on EDEM1, the full-length protein sequence 
was queried using PONDR-FIT, DISOPRED, DisProt, FoldIndex (Prilusky et al., 2005; 
Sickmeier et al., 2007; Ward et al., 2004; Xue et al., 2010). Each algorithm, with the 
exception of one, identified two regions that are predicted as IDRs, located at the N- and 
C-termini of the protein (Figure 3.5A, left panel). These IDRs constitute the bulk of the 
sequence flanking the MLD, making them potential modes of interaction between 
EDEM1 and ER quality control machinery or other possible ERAD clients. 
ER Localization of the EDEM1 constructs 
To investigate the role of the EDEM1 IDRs in localization and to determine if a 
construct comprised solely of the MLD lacking both IDRs remains ER localized, we 
generated constructs lacking either IDRs (ΔIDR (N), and ΔIDR (C)) or both (MLD), 
which comprises the mannosidase-like domain alone (Figure 3.5A, right panel). Each 
construct contains the putative WT EDEM1 signal sequence, as well as the same FLAG 
epitope at the C-terminus. In order to address whether the truncated constructs are 
targeted to the ER, their subcellular localization was monitored by confocal 
immunofluorescence microscopy (Figure 3.5B) and by endoglycosidase sensitivity (Fig. 
3A). 
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Single transfections of FLAG-tagged EDEM1 FL, ΔIDR(N), ΔIDR(C), and MLD 
were performed in HEK293A cells and staining was compared against ER (CRT) or 
Golgi (Giantin) markers (Figure 3.5B). Signals from each EDEM1 construct colocalized 
with CRT; however, no colocalization was observed with the Golgi marker, suggesting 
that all constructs were ER resident proteins.  
EDEM1 and the IDR constructs are predicted to possess multiple N-linked 
glycosylation consensus sites. EDEM1 FL was previously shown to be N-glycosylated, 
thus an N-glycosylation assay would reveal if the EDEM1 constructs lacking the IDRs 
were targeted to and reside in the ER (Tamura et al., 2011). The proteins were isolated by 
immunoprecipitation from cells expressing EDEM1 FL, ΔIDR(N), ΔIDR(C), and MLD, 
and were de-glycosylated using PNGase F (F), Endo H (E), or untreated (U) (Figure 
3.6A) and visualized by immunoblotting. PNGase F removes mannose-rich N-glycans 
found in the ER, as well as complex N-glycans that are acquired in the Golgi, while Endo 
H only trims high mannose N-glycans encountered in the ER. Since the molecular mass 
of an N-linked glycan is approximately 2.5 kDa, glycosylated proteins should migrate 
slower on an SDS-PAGE gel compared to de-glycosylated proteins.  
Mobility shifts upon PNGase F and Endo H treatment were observed for all 
EDEM1 IDR constructs (Figure 3.6A, compare “U” lanes to “P” and “E” lanes), 
indicating that ΔIDR(N), ΔIDR(C), and MLD were all targeted to the ER and 
glycosylated with high mannose carbohydrates and did not receive complex N-glycans in 
the Golgi. Together, these observations are consistent with ΔIDR(N), ΔIDR(C), and 
MLD being targeted to and residing in the ER. 
 49 
 
EDEM1 MLD preferentially interacts with ERAD substrates  
To attempt to reduce EDEM1 down to a smaller functional unit and to determine 
if the conserved N- and C-terminal MLD flanking regions are required for ERAD client 
binding, the binding of the EDEM1 constructs to A1AT WT and its mutant variants was 
characterized using a radiolabel pulse-chase approach (Figure 3.6B). The IDRs were not 
required for the interaction with Z and NHK as binding to Z and NHK but not WT 
occurred for both E Figure 3.6B, lanes 8, 9 14 and 15, 
compared to lanes 7 and 13). The MLD construct, which is missing both the N- and C-
terminal IDRs, also preferentially binds to misfolded variants Z and NHK over WT 
(Figure 3.6B, lanes 16-18).  
Moreover, the three-acidic putative active site residues were replaced with 
positively charged Lys residues (MLD (3K)) to abolish any potential carbohydrate 
binding (Figure 3.6C, lanes 7-9). Interestingly, the interaction between MLD (3K) and 
both NHK and Z was maintained while no interaction was observed with WT A1AT; 
which further validates the ERAD-client specific glycan-independent binding property of 
the MLD. The MLD also bound to a non-glycosylated NHK indicating that binding was 
glycan-independent (Figure 3.6D). Taken together, these results demonstrate that the 
EDEM1 MLD possesses the ability to preferentially interact with the non-native ERAD 
clients NHK and Z, in a glycan-independent manner. 
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MLD substrate binding is redox sensitive 
Since the EDEM1 MLD exhibits preferential interaction with ERAD clients, we 
next determined if this interaction involves thiols by monitoring binding upon the 
addition of DTT (Figure 3.7A). A pulse chase analysis was performed (as described in 
Fig. 1A) using a sequential immunoprecipitation of the protein with anti-FLAG followed 
by anti-A1AT (Figure 3.7A, lanes 7-12). As expected, the MLD did not interact with WT 
A1AT (Figure 3.7A, lanes 7 and 8). However, like full length EDEM1, the interaction 
between Z and NHK was oxidation dependent under stringent detergent conditions 
(Figure 3.7A, compare lanes 10 to 9, and 12 to 11).   
We next determined if the thiol-dependent interaction involves Cys256 for 
Z/NHK (Figure 3.7B). The MLD was co-expressed in HEK293T cells with A1AT WT, 
Z, Z Cys256Ser, NHK, NHK Cys256Ser, NHK NOG, and NHK NOG Cys256Ser. The 
proteins were radiolabeled for 30 min, and chased for 1 hr. The cells were lysed under 
stringent detergent conditions (TX/SDS) and protein complexes were isolated by single 
anti-A1AT and anti-FLAG immunoprecipitation, as well as sequential 
immunoprecipitation. The Cys256 residue on NHK/Z also plays a role in the interaction 
with the MLD, as the Cys to Ser mutations abolished the interaction (Figure 3.7B, 
compare lanes 6 to 5, 15 to 14, and 17 to 16). 
The EDEM1 Cys at position 160, 410, 457, and 529 are predicted to be involved 
in disulfides (Figure 3.3E) and are all found in the MLD. Additionally, our PEG-
maleimide analysis revealed that these Cys do not appear modified under oxidizing 
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conditions, suggesting that they are either involved in disulfide interactions or not 
accessible to maleimide modification.  
The modeled structure of the MLD predicts two potential disulfides and two 
unpaired Cys (Figure 3.3E). Our PEG-maleimide analysis on full-length EDEM1 
identified approximately four reactive thiols and approximately four thiols that are 
inaccessible to maleimide modification (Figure 3.3B and Figure 3.4A).  Based on these 
results, we expect that a subset (~2) of the Cys on the MLD will be accessible to 
maleimide modification, while the remaining four would not be. Like the full-length 
EDEM1, a subset of the Cys residues on MLD is reactive at steady state (Figure 3.7C, 
compare lane 3 to lanes 1, 2 and 4). 
Next, we determined whether the Cys that are predicted to be paired and 
experimentally inaccessible to PEG-maleimide (Cys160, 529, 410, and 457) are involved 
in the thiol-dependent interaction between MLD and Z/NHK (Figure 3.8). Each of the 
Cys/Ser combinational mutants were co-expressed in HEK293T cells with WT A1AT, Z 
and NHK. Radiolabeled proteins were isolated using single immunoprecipitation with 
anti-A1AT antibody (Figure 3.8, lanes 1-3, 10-12, 19-21, 28-30, and 37-39), anti-FLAG 
(Figure 3.8, lanes 7-9, 16-18, 25-27, 34-36, and 43-45), and by sequential 
immunoprecipitation (Figure 3.8, lanes 4-6, 13-15, 22-24, 31-33, and 40-42).   
Binding to WT A1AT was not observed, regardless of the mutation (Figure 3.8, 
compare lanes 13, 22, 31 and 40 to lane 4). Binding to Z and NHK persisted when either 
predicted disulfide pairs, or free thiols were mutated (Figure 3.8, compare lanes 14, 15, 
23, 24, 32, 33, to lanes 5 and 6). However, the Cys-less construct did not exhibit any 
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binding to Z or NHK (Figure 3.8, compare lanes 41 and 42 to lanes 5 and 6), which is 
likely due to which is likely due to the resulting compromised structural integrity of the 
Cys-less MLD. 
Altogether, the MLD possesses the ability to bind NHK and Z in a thiol-
dependent manner, involving Cys256 on Z/NHK. However, the MLD Cys that are 
predicted to be involved in disulfides, like the predicted unpaired Cys, are not directly 
involved in this interaction. Cys residues appear to function as structural components of 
the MLD, and at least one of these disulfides pairs is required for ERAD client binding. 
EDEM1 MLD promotes glycan trimming 
To further characterize the MLD and elucidate whether it possesses mannose-
trimming properties, the mobility of NHK on SDS-PAGE was monitored (Figure 3.9). A 
quadruple knockout CRISPR/Cas9 CHO cells was used where four mannosidases were 
knocked out (Man1a1/a2/b1/c1). The only putative mannosidases that are present in these 
knockout cell lines are EDEM1, 2 and 3. Thus, overexpressing the MLD in these cell 
lines might enhance any trimming effect on NHK as the presence and effect of other 
functional mannosidases is minimized. 
NHK was co-expressed in the quadruple mannosidase knockout CHO cells with a 
mock empty plasmid (Figure 3.9, lanes 1-6), the catalytically active Man1b1-FLAG 
(Figure 3.9, lanes 7-12), EDEM1-FLAG (Figure 3.9, lanes 13-18), EDEM1 (3K)-FLAG 
(Figure 3.9, lanes 19-24), MLD-FLAG (Figure 3.9, lanes 25-30), MLD (3K)-FLAG 
(Figure 3.9, lanes 31-36), and MLD Cys-less-FLAG (Figure 3.9, lanes 37-42), in addition 
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to NHK with the mannosidase inhibitor, kifunensine (Kif) (Figure 3.9, lanes 43-45). 
Proteins were radiolabeled for 30 min and chased the indicated times. 
Consistent with previous data, mannose trimming was abolished upon the 
addition of kifunensine (Figure 3.9, lanes 43-45) and the mutation the acidic putative 
active site residues on EDEM1 (Figure 3.9, compare lanes 22-24 to lanes 16-18). 
Importantly, the MLD also possesses glycan-trimming ability, as observed by the 
increase in mobility of NHK upon co-expression with MLD (Figure 3.9, lanes 28-30) 
compared to MLD (3K) (Figure 3.9, lanes 34-36). These results indicate that the MLD is 
properly folded and possesses glycosidase activity. 
Role of IDRs in EDEM1 stability and function 
 Given that the MLD exhibited similar substrate binding properties as that of the 
full-length EDEM1, we wanted to determine if it possessed similar inherent properties of 
EDEM1, specifically its short half-life, and the ability to associate with another known 
EDEM1 binding partner, ERdj5.  
Half-lives: EDEM1 is reported to have a rapid turnover rate with a half-life of ~2 
hr (Le Fourn et al., 2009), especially compared to other ER resident proteins such as BiP, 
a key member of the ER quality control machinery, which is in the range of 28-33 hr 
(Gülow et al., 2002).  Furthermore, proteins that are intrinsically disordered or contain 
IDRs possess, on average, a shorter half-life than proteins lacking any IDRs (van der Lee 
et al., 2014). Specifically, proteins containing long stretches of disordered regions (>30 
residues) appear to have the shortest half-lives. The EDEM1 N- and C-terminal IDR 
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regions are predicted to be 71 and 69 amino acids in length, respectively (Figure 3.5A, 
right panel).  
We thus postulated that the MLD construct, which lacks both IDRs, would have 
the longest half-life. To this end, each construct bearing a C-terminal FLAG epitope was 
expressed in HEK293T cells and subjected to a pulse-chase experiment after 
radiolabeling. Following lysis, the proteins were isolated through immunoprecipitation 
and resolved on SDS-PAGE (Figure 3.10, top panel). The amount of protein remaining at 
the indicated time points was quantified and normalized to the starting amount (Figure 
3.10, bottom panel).   
Approximately 50% of EDEM1 FL remained at the 2 hr time point while only 
~20% remained at 4 hr. These results are consistent with previous turnover rates of 
EDEM1 in cell analyses (Le Fourn et al., 2009). However, the half-life of the MLD 
construct, which lacks both IDRs, was ~4 hr, (~70% remains at 2 hr). Similarly, the 
constructs lacking each IDR individually (ΔN/ ΔC) have longer half-lives than the full-
length construct. These observations further validated the identity and presence of two 
IDRs on EDEM1 that contribute to the previously observed short half-life of EDEM1. 
ERdj5 binding: Since the IDRs were not required for substrate interaction with 
A1AT misfolded variants (Figure 3.6B, 2.6C and 2.6D), we next determined whether the 
IDRs of EDEM1were required for binding to the ER oxidoreductase ERdj5. To this end, 
FLAG-tagged full-length EDEM1, the EDEM1 IDR deletion constructs, and the MLD 
were co-expressed with MYC-tagged ERdj5 in HEK293T cells. The cells were lysed 24 
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hr post-transfection and proteins were isolated through co-immunoprecipitation. Binding 
interactions were monitored through immunoblotting.  
An interaction with ERdj5 was recovered with EDEM1 lacking either one of its 
IDRs (Figure 3.11, compare lanes 5, 6, 8, and 9 to lanes 2 and 3). However, the 
interaction with ERjd5 was lost with EDEM1 lacking both IDRs as displayed by the 
MLD (Figure 3.11, compare lanes 11 and 12 to 2 and 3). This indicated that the presence 
of either IDRs was sufficient to interact with ERdj5 but the interactions was abolished 
when both IDRs were removed with the EDEM1 MLD.  
Taken together, these studies with EDEM1 MLD established its ER localization, 
determined its substrate binding properties, identified components that support binding to 
ERdj5, and confirmed it possesses catalytic glycosidase activity in cells. 
Conservation of EDEM1 properties in EDEM2 and EDEM3. 
To determine if EDEM2 and EDEM3 contain similar properties to EDEM1, 
EDEM2 and EDEM3 were characterized for substrate binding properties, free thiol 
content and analyzed for IDRs. Human EDEM2 and EDEM3 were co-expressed in 
HEK293T cells with WT A1AT, Z, Z Cys256Ser, NHK, NHK Cys256Ser, NHK NOG, 
and NHK NOG Cys256Ser. The proteins were radiolabeled for 30 min, and chased for 1 
hr. Cells were lysed under stringent detergent conditions (TX/SDS), lysates were split 
into equal portions, and protein complexes were isolated by anti-FLAG or anti-A1AT 
immunoprecipitation. Neither EDEM2 nor EDEM3 associate with WT A1AT (Figure 
3.12A and Figure 3.13A, lane 6).  
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Like EDEM1 and the MLD, EDEM2 and EDEM3 co-immunoprecipitated with 
the ERAD clients, Z and NHK (Figure 3.12A and Figure 3.13A, lanes 7 and 9) in a 
glycan-independent manner (Figure 3.12A and Figure 3.13A, lane 13). However, upon 
mutating Cys256 to Ser, the interaction was lost (Figure 3.12A and Figure 3.13A, 
compare lanes 8 to 7, 10 to 9, and 14 to 13), suggesting that the thiol-dependency that is 
observed with EDEM1 and EDEM1 MLD is a conserved trait among all human EDEM 
homologues.  
Human EDEM2 and EDEM3 possess numerous Cys, 9 and 11, respectively 
(Figure 3.12B and Figure 3.13B). When subjected to PEG-maleimide modification, both 
construct displayed reactive thiols at steady state (Figure 3.12B and Figure 3.13B, 
compare lane 3 to lanes 1, 2 and 4). Additionally, the EDEM2 and EDEM3 protein 
sequences were queried for IDRs and like EDEM1, both proteins possess IDRs in regions 
outside the MLD, specifically at the C-terminus (Figure 3.12B and Figure 3.13B).  
Together, these results indicate that EDEM1, 2, and 3 possess a conserved redox-
sensitivity involved in binding to A1AT ERAD substrates. The proteins are predicted to 
contain IDRs; however, in the case of EDEM1, these regions do not contribute to Z/NHK 
binding, as the catalytically active EDEM1 MLD alone is capable of selectively binding 
to ERAD clients. 
Discussion 
Protein-to-protein interactions have been observed between EDEM1 and multiple 
ERAD clients including BACE457, CFTR, Rhodopsin, H2a and A1AT (Cormier et al., 
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2009; Gnann et al., 2004; Hosokawa et al., 2001; Kosmaoglou et al., 2009; Molinari et 
al., 2003; Shenkman et al., 2013). However, the basis for these substrate-binding 
interactions is uncertain. Here we studied the interaction between EDEM1 and the 
misfolded A1AT variants Z and NHK. An additional mode of interaction that is redox 
sensitive was revealed and provided further evidence that the MLD is active and 
sufficient to selectively bind the A1AT ERAD clients, Z and NHK.   
EDEM1 preferentially interacts with Z and NHK, but does not bind to the WT 
A1AT, suggesting it may recognize elements on these misfolded proteins that are not 
present on the properly folded substrate (Cormier et al., 2009). In the presence of a 
reducing agent, the interactions between EDEM1 and Z/NHK were lost under stringent 
detergent conditions (Figure 3.1). However, under milder detergent condition, the 
interactions persisted (Figure 3.1) demonstrating the involvement of two types of 
interactions: a strong covalent-like, oxidation-dependent interaction; as well as a weak, 
protein-protein interaction as demonstrated by the recovered interaction under milder 
detergent conditions.  
The latter protein-protein interactions are possibly mediated through hydrophobic 
interactions as such interactions have been demonstrated between EDEM1 and the ERAD 
client BACE457 (Sokołowska et al., 2015). A model of the EDEM1 MLD structure 
shows extensive surface exposed hydrophobic patches on EDEM1 (Figure 3.14), all of 
which may mediate the observed weak protein-protein interactions. Identifying the 
precise hydrophobic patch(es) involved in this interaction, or determining whether other 
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ERAD clients or machinery interactions involve hydrophobic interactions with EDEM1 
will require further investigation.  
The lone cysteine residue located on Z and NHK (Cys256) contributed to the 
observed oxidation-dependent interaction with EDEM1 (Figure 3.2A, and 2.2B) as the 
interaction was lost upon mutating the Cys to Ser under strong detergent conditions but 
persisted under mild detergent conditions. This supports the observed oxidation 
sensitivity, presumably through a disulfide bond (Figure 3.2B). Interestingly, Cys256 is 
located in the WT structure in a position that is partially exposed or buried (Figure 3.15).  
Mutations as those observed with NHK and Z would be expected to perturb the 
structure sufficiently to support increased accessibility of Cys256 to quality control 
factors and ERAD machinery. The presence of aberrant Cys256-mediated dimers that are 
formed between Z monomers and NHK monomers, that do not occur with WT A1AT, as 
well as increased secretion of Z upon Cys256 to Ser mutation, implicate a role for the 
Cys in ER retention of aberrantly folded Z, and perhaps NHK, as well as further provide 
evidence supporting the increased accessibility of Cys256 on Z compared to WT A1AT.  
This suggests that Cys256 is suitably positioned to act as a quality control signal 
when exposed in aberrant structures. Although, a heterodimer between the two proteins 
(Z and EDEM1 or NHK and EDEM1) was not readily observable (data not shown), it is 
likely that since EDEM1 is proposed to exist in the ER as a member of a multi-protein 
complex, the presence of monomeric or dimeric Z or NHK would not result in an 
observable mobility shift on non-reducing SDS-PAGE.   
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A putative model of the EDEM1 MLD showed a conserved barrel structure with the 
three-putative acidic catalytic residues centered at the core, similar to that of Man1b1 
(Figure 3.3E, and 1.5) (Vallée et al., 2000). The model also revealed two potential 
disulfides as indicated by their predicted proximities, and two unpaired Cys. The 
predicted map and the presence of reactive thiols, was further tested upon subjection of 
combinational Cys to Ser mutants of the predicted unpaired Cys residues to peg-
maleimide modification (Figure 3.4A).  
Given the oxidative nature of the ER and the role of EDEM1 in ERAD, it is 
surprising that four out of the eight Cys on EDEM1 appear to be accessible to maleimide 
modification at steady state and suggest that these Cys are likely involved in a functional 
aspect of EDEM1, either to form direct stable or transient bonds with ERAD clients, 
ERAD machinery or with other EDEM1 proteins. However, none of the individual Cys 
were required to interact with Z or NHK (Figure 3.4B) The interaction was only 
abolished when all Cys were mutated to Ser (Cys-less), in which case the protein was 
likely unstructured. These results further support the absence of direct involvement of the 
Cys of EDEM1 in the apparent redox sensitive interaction with Z/NHK.   
The redox sensitivity of EDEM1 substrate selection likely involves an oxidoreductase 
other than ERdj5 since the MLD exhibits redox sensitive binding to Z/NHK (Figure 3.7A 
and 2.7B) and does not interact with ERdj5 (Figure 3.11). It is likely that the interaction 
between EDEM1 and ERdj5 does not require the MLD, as EDEM1 appears to interact 
with ERdj5 through its C-terminal thioredoxin cluster, a region that is not glycosylated 
(Ushioda et al., 2008).   
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Several groups have demonstrated an interaction between EDEM1 and multiple 
oxidoreductases including P5, PDI, ERp57, and ERp72 (Jansen et al., 2012; Jessop et al., 
2009). Likewise, ERdj3 was recently implicated in the degradation of the Z variant 
(Khodayari et al., 2017). Additionally, the EDEM3 MLD was recently discovered to form 
a disulfide bond with the oxidoreductase ERp46, which promoted the catalytic activity of 
EDEM3 (Yu et al., 2018). Whether these oxidoreductases or others are involved in the 
redox-sensitive substrate-binding properties of EDEM1 remains to be determined.  
The truncated MLD construct, in which both regions flanking the EDEM1 MLD were 
removed, was used to assess the requirement of paired Cys residues in the EDEM1-
Z/NHK interaction.  The fundamental properties of the MLD were characterized.  
Although the EDEM2 MLD was expressed and characterized both in cells and as a 
recombinant protein, the properties of the EDEM1 MLD alone are uncharacterized. The 
EDEM1 MLD construct is targeted to and retained in the ER, in contrast to the EDEM2 
MLD (Figure 3.5B and 2.6A) (Mast et al., 2005). Importantly, the MLD alone retained 
the ability to preferentially interact with ERAD clients in a glycan-independent manner, 
indicating that the mannosidase-like domain is sufficient to interact and preferentially 
select A1AT ERAD substrates further reinforcing the MLD requirement in binding to a 
subset of ERAD clients (Figure 3.6C and 2.6D).  
The MLD also exhibited the same oxidation dependent binding and sensitivity to the 
Z/NHK Cys256 upon stringent detergent condition, indicating that the ability and 
selectivity for Z and NHK binding is inherent to the MLD and did not require the 
flanking IDRs (Figure 3.7A and 2.7D). However, the covalent interaction is likely 
mediated through a co-factor, as neither of the predicted disulfides was involved. 
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Although the eight-Cys residues on EDEM1 are conserved across species, at least a 
subset of them appear to function as structural elements of the MLD, as indicated by loss 
of ERAD client binding in the absence of all Cys residues (Figure 3.8).  
In addition, the MLD expressed in a cell line deficient for four mannosidases 
including Man1a1/a2/b1/c1 exhibited mannose-trimming properties as observed by the 
mobility shift of NHK on SDS-PAGE (Figure 3.9). The mobility shift was lost upon the 
mutation of the putative catalytic residues (MLD 3K), suggesting that the catalytically 
inactive MLD 3K exhibited a dominant negative effect, one in which NHK binds the 
inactive MLD thus preventing it from interacting with other mannosidases such as 
EDEM2 or EDEM3 (Figure 3.9) (Ninagawa et al., 2015). EDEM1 does not appear to act 
solely as a mannosidase as selective interactions with ERAD clients survive prolonged 
binding required with the co-immunoprecipitation protocol, unlike Man1b1 for which an 
interaction is not recovered. It is possible that this prolonged interaction indicates a role 
for EDEM1 in delivering ERAD clients to the retro-translocation machinery. Altogether, 
these novel findings may facilitate purification of recombinant EDEM1 and its MLD for 
in vitro biochemical characterization, which have previously been unsuccessful and 
potentially help identify the specific glycan branch on which EDEM1 acts.    
In addition to identifying novel redox sensitive properties between EDEM1 or the 
MLD and two ERAD substrates, we have identified a second IDR located at the C-
terminus of EDEM1 (Figure 3.5A). Removing either or both IDRs did not affect the ER 
targeting or localization of EDEM1 as all constructs received N-linked glycans and 
exhibited glycoforms that are typically found on ER-resident proteins (Figure 3.6A). 
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None of the constructs were recovered in the media fractions, confirming their cellular 
retention (Figure 3.6A). The ER retention of the MLD alone appears to require neither a 
retention sequence like KDEL nor the N- or C- terminal regions flanking it. Instead, the 
ER retention of soluble EDEM1 is a property of the MLD unlike that of EDEM2, 
demonstrating a key difference between the proteins (Figure 3.5B and 2.6A) (Mast et al., 
2005). The construct lacking either IDR also retained the glycan-independent preferential 
interaction with Z and NHK, which is expected as both constructs display intact MLDs 
(Figure 3.6B and 2.6D).  
The present study provides evidence that EDEM1 possesses two IDRs that 
contribute to its observed short half-life. Unlike other ER resident proteins such BiP, 
EDEM1 is rapidly turned over and exhibits a half-life of ~2 hr. The stability of EDEM1 
upon removal of both IDRs (EDEM1 MLD) appears to double the protein half-life from 2 
to 4 hr, which further supports the regions flanking the EDEM1 MLD as intrinsically 
disordered (Figure 3.10). 
The relatively short half-life of EDEM1 is likely linked to its function in ERAD to 
bind misfolded clients as they accumulate in the ER and target them for degradation. The 
short half-life is also proposed as a function of ERAD tuning in order to return the ER to 
basal EDEM1 levels once the stress is alleviated (Merulla et al., 2013). The conservation 
of the IDRs across EDEM1 in various species further supports their necessity and role in 
its function (data not shown). 
Although neither the N- nor C-terminal IDRs were required for binding to Z or 
NHK, unlike H2a or soluble tyrosinase, either IDRs appear necessary for binding to 
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ERdj5 (Figure 3.11) (Marin et al., 2012; Shenkman et al., 2013). Like EDEM1, other 
proteins such as the E3 ligase San1 and the deubiquitinating enzyme Ubp10 possess IDRs 
at both their N- and C- termini (Fredrickson et al., 2011; Reed et al., 2015). In both cases, 
the conformational flexibility of the IDRs allows San1 and Ubp10 to bind multiple 
partners. EDEM1 may use an analogous mechanism to bind partners such as ERdj5. 
EDEM2 and EDEM3 interact with and accelerate the degradation of Z and NHK 
(Jang et al., 2015; Ninagawa et al., 2015; Hirao et al., 2006). This interaction also appears 
sensitive to the presence of Cys256 on NHK and Z (Figs. 7A and B). EDEM2 and 
EDEM3 also possess reactive thiols at steady state (Figure 3.12A ad 2.13A), and interact 
with the oxidoreductase TXNDC11 (Timms et al., 2016). Like EDEM1, EDEM2 and 
EDEM3 are predicted to possess IDRs (Figure 3.12B ad 2.13B). These findings further 
support conserved properties among the mammalian EDEM protein family. 
Together, these findings uncover new modes of interaction that EDEM1 possesses 
and broaden the binding landscape of EDEM1. Specifically, EDEM1 does not interact 
with its binding partners or ERAD clients in a “one size fits all” manner.  Instead, 
EDEM1 binding is multifaceted as different components are utilized depending on the 
properties or requirement of the specific binding partner increasing the versatility of its 
substrate selectivity. 
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Figure 3.1 EDEM1 binding to ERAD clients A1AT Z and NHK is bipartite 
EDEM1-FLAG was transiently transfected with A1AT WT, NHK, or Z in HEK293T 
cells. Cells were radiolabled with [35S]-Cys/Met for 30 min and chased for 15 min. DTT 
(5 mM) was added to the cells for 30 min where indicated (+DTT). Cells were lysed in 
MNT buffer containing Triton X-100 (TX) or CHAPS (CH). Lysates were split in half 
and EDEM1 and A1AT were isolated using anti-FLAG (α-FLAG) and anti-A1AT (α-
A1AT) antisera. The proteins were resolved on 9% reducing SDS-PAGE. 
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Figure 3.2 EDEM1 binding to ERAD clients A1AT Z and NHK involves C256  
(A) Cartoon representation of A1AT constructs depicting signal peptide (green), 
glycosylation sites (black), and Cys256 (yellow). Arrows denote point mutation E366K 
on Z and frameshift mutation at 342 on NHK. (B) EDEM1-FLAG was co-expressed in 
HEK293T cells with A1AT WT, Z, Z C256S, NHK, or NHK C256S. The proteins were 
radiolabeled with [35S]-Cys/Met for 30 min and chased for 1 hr. Cells were lysed in 2% 
CHAPS or MNT buffer containing 0.1% SDS. Half of the cell lysate was subjected to 
anti-A1AT immunoprecipitation while the other half to anti-FLAG immunoprecipitation, 
and washed in 0.5% CHAPS or wash buffer containing 0.1% SDS, respectively. Proteins 
were resolved on 9% reducing SDS-PAGE. Gels are representative of three independent 
experiments. 
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Figure 3.3 EDEM1 possesses approximately 4 reactive thiols 
(A) Cartoon representation of a protein possessing two cysteines involved in an 
intramolecular disulfide bond and two unpaired cysteines. The presence of free thiols is 
analyzed using sulfhydryl-reactive maleimide linked to a polyethylene glycol group 
(PEG-Mal). Cells expressing the protein of interest are treated with or without DTT to 
assess reducing and non-reducing states, respectively. Cells are lysed in the presence and 
absence of PEG-maleimide, and protein samples are resolved by SDS-PAGE.  (B) 
EDEM1-FLAG was expressed in HEK293T cells. Cells were pretreated with DTT (5 
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mM) where indicated (+/-). Cells were lysed in sample buffer containing 5 mM peg-
maleimide (+ PEG-Maleimide) or 20 mM NEM (- PEG-Maleimide). Proteins were 
resolved on 8.5% SDS-PAGE and immunoblotted with FLAG antibody (C) Cartoon 
representation of amino acid sequence alignments (Clustal Omega) of EDEM1 from 
various species (Accession #:NP_055489.1, XP_004033576.1, JAA36785.1, 
NP_001252679.1, AAI51306.1, NP_619618.1, and NP_001091440.1) depicting 
conserved and non-conserved Cys residues, black and red check marks, respectively. (D) 
FLAG-tagged EDEM1 WT, EDEM1 C95/302/555/629S (4Cys), EDEM1 C95/302/629S 
(5Cys), EDEM1 C95/302S (6Cys), and EDEM1 C95S (7Cys) were transfected in 
HEK293T cells. 5 mM DTT was added for 1 h where inidcated (+). Cells were lysed in 
sample buffer containing 5 mM peg-maleimide (+ PEG-Maleimide) or 20 mM NEM (- 
PEG-Maleimide). Proteins were resolved on 8.5% SDS-PAGE and immunoblotted with 
FLAG antibody. Gel represents data acquired from three independent experiments. (E) 
Structural model (Phyre2.0) of the MLD (Cyan) showing the three catalytic triad (red) 
and Cys residues (yellow). Cartoon representation of EDEM1 depicting signal peptide 
(green), MLD (cyan), putative catalytic residues (red), Cys residues (yellow), and 
predicted disulfides (*).   
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Figure 3.4 EDEM1 Cys at position 95/302/555/629 are unpaired but not required 
for NHK/Z binding 
(A) FLAG-tagged EDEM1 (WT), C95/302S, C555/629S, C95/302/629S, and 
C95/302/555/629S were expressed in HEK293T cells. 5 mM DTT was added for 1 h 
where inidcated (+). Cells were lysed in sample buffer containing 5 mM peg-maleimide 
(+ PEG-Maleimide) or 20 mM NEM (- PEG-Maleimide). Proteins were resolved on 
8.5% SDS-PAGE and immunoblotted with FLAG antibody. Gel represents data acquired 
from three independent experiments.  (B) FLAG-tagged EDEM1 WT, C95S, C160S, 
C302S, C410S, C457S, C529S, C555S, C629S and empty plasmid (-) were co-expressed 
in HEK293T cells with NHK. The proteins were radiolabeled with [35S]-Cys/Met for 30 
min and chased for 1 hr. Cells were lysed in MNT buffer containing Triton X-100. Half 
of the cell lysate was subjected to anti-A1AT immunoprecipitation while the other half to 
anti-FLAG immunoprecipitation, and washed in buffer containing 0.1% SDS. Proteins 
were resolved on 9% reducing SDS-PAGE. Gels are representative of three independent 
experiments. (C) FLAG-tagged EDEM1 (WT), C95/302/629S, and C95/302/555/629S 
were co-expressed with A1AT WT, Z, and NHK in cells. Cells were radiolabled with 
[35S]-Cys/Met for 30 min and chased for 1 hr. Cells were lysed in MNT buffer 
containing 0.1% SDS. Half of the cell lysate was subjected to anti-A1AT and half to anti-
FLAG immunoprecipitation. Proteins were resolved on 8.5% reducing SDS-PAGE. 
Asterisk denotes background bands. Gels are representative of three independent 
experiments. 
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Figure 3.5 EDEM1 constructs lacking either or both IDRs are targeted to the ER 
(A) (Left) Cartoon representation of human EDEM1 depicting signal sequence (green), 
MLD (cyan), and predicted disordered regions (black). (Right) FLAG-tagged EDEM1 
constructs lacking either IDRs (ΔIDR N and ΔIDR C) or both (MLD). (B) Images of 
exogenously expressed FLAG-tagged EDEM1, EDEM1 ΔIDR (N), EDEM1 ΔIDR (C), 
and MLD obtained by confocal microscopy. Fixed cells were stained with FLAG, CRT 
(ER), or Giantin (Golgi) antisera. Nuclei were visualized by DAPI staining (Blue). Scale 
bars correspond to 10 μm.  
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Figure 3.6 EDEM1 lacking IDRs is retained in the ER and preferentially interacts 
with ERAD substrates in a glycan-independent manner 
(A) HEK293T cells were transfected with FLAG-tagged EDEM1-FL, -ΔIDR(N), -
ΔIDR(C) and MLD. Cells were lysed in MNT buffer. Lysate and media samples were 
subjected to anti-FLAG immunoprecipitation and proteins samples were treated with 
PNGaseF, EndoH, or left untreated (U). Proteins were resolved on a 7.5% reducing SDS-
PAGE and immunoblotted against FLAG. Asterisk denotes IgG heavy chain. (B) Empty 
plasmid (-), EDEM1 (FL)-FLAG, ΔIDR(N)-FLAG, ΔIDR(C)-FLAG and MLD-FLAG 
constructs were co-transfected with the A1AT WT, Z and NHK in HEK293T cells. 
Proteins were radiolabeled for 30 min with [35S]-Cys/Met and chased for 1 hr. Lysates 
were subjected to sequential (first anti-FLAG, second anti-A1AT), or single anti-A1AT 
immunoprecipitation. Proteins were resolved on reducing 8% SDS-PAGE. (C) MLD-
FLAG, MLD (3K)-FLAG, and empty plasmid (Mock) were co-expressed with WT 
A1AT, Z, or NHK in HEK293T cells. Cells were radiolabled with [35S]-Cys/Met for 30 
min and chased for 1 hr. Cells were lysed in MNT buffer containing Triton X-100. 70% 
of the lysate was subjected to sequential immunoprecipitation (first anti-FLAG, second 
anti-A1AT), and 20% to anti-A1AT immunoprecipitation. The proteins were resolved on 
8% reducing SDS-PAGE. (D) FLAG-tagged EDEM1 WT, ΔIDR (N), ΔIDR (C), and 
MLD were co-expressed in HEK293T cells with NHK NOG. The proteins were 
radiolabeled with [35S]-Cys/Met for 30 min and chased for 1 hr. Cells were lysed in 
MNT buffer. Half of the cell lysate was subjected to anti-FLAG immunoprecipitation 
while the other half to anti-A1AT immunoprecipitation. Proteins were resolved on 9% 
reducing SDS-PAGE. Gels are representative of three independent experiments. 
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Figure 3.7 EDEM1 MLD interacts with Z/NHK through Cys256 and possesses 
reactive thiols 
(A) MLD-FLAG was co-expressed with A1AT WT, Z, or NHK into HEK293T cells. 
Cells were radiolabled for 30 min and chased for 15 min. DTT (5 mM) was added to the 
cells for 30 min where indicated (+DTT). Cells were lysed in MNT buffer containing 
Triton X-100 (TX). A portion of the lysate (65%) was subjected to sequential 
immunoprecipitation (first anti-FLAG, second anti-A1AT), 20% to anti-A1AT, and 10% 
to anti-FLAG. The proteins were resolved on 8% reducing SDS-PAGE. (B) MLD-FLAG 
was co-expressed with A1AT WT, Z, Z C256S, NHK, NHK C256S, NHK NOG, and 
NHK NOG C256S in HEK293T cells. Cells were radiolabled for 30 min and chased for 1 
hr and lysed in MNT buffer. Proteins were immunoprecipitated as in A and resolved on 
8% reducing SDS-PAGE. Asterisk denotes background band. (C) MLD-FLAG was 
expressed in HEK293T cells. Cells were pretreated for 1 hr with DTT (5 mM) where 
indicated (+/-). Cells were lysed in sample buffer containing 5 mM peg-maleimide (+ 
PEG-Maleimide) or 20 mM NEM (- PEG-Maleimide). Proteins were resolved on 8% 
SDS-PAGE and immunoblotted against FLAG antibody. Gels are representative of three 
independent experiments.  
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Figure 3.8 EDEM1 MLD Cys-less does not interact with NHK/Z 
MLD-FLAG, MLD C160/529S, MLD C410/457S, MLD C302/555S, and MLD Cys-less 
were co-expressed in HEK293T cells with WT A1AT, Z or NHK. The proteins were 
radiolabeled for 30 min and chased for 1 hr. Cells were lysed in MNT buffer containing 
Triton X-100 (TX). A portion of the lysate (65%) was subjected to sequential 
immunoprecipitation (first anti-FLAG, second anti-A1AT), 20% to anti-A1AT, and 10% 
to anti-FLAG. The proteins were resolved on 8% reducing SDS-PAGE. Gels are 
representative of three independent experiments  
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Figure 3.9 EDEM1 MLD promotes glycan trimming 
(Top and middle panels) Empty plasmid (Mock), Man1b1-FLAG, EDEM1-FLAG, 
EDEM1 (3K)-FLAG, MLD-FLAG, MLD (3K)-FLAG, MLD (Cys-less)-FLAG and 
empty plasmid (mock) were co-expressed with NHK in Man1a1/a2/b1/c1 KO CHO cells. 
150 mM Kifunensine (KIF) was added for 5 hr prior to the pulse, where indicated. 
Proteins were radiolabeled for 30 min with [
35
S]-Cys/Met and chased for 0, 1, and 2 hr. 
Cells were lysed in MNT buffer and lysates were divided equally and subjected to anti-
FLAG and anti-A1AT immunoprecipitation. Proteins were resolved on reducing 8% 
SDS-PAGE. (Bottom panels) The NHK bands in the designated lanes was magnified and 
a red line was drawn through the center of each 0 hr time point and through 2 hr time 
point to illustrate mobility shifts. Gels are representative of three independent 
experiments. 
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Figure 3.10 EDEM1 IDRs contribute to its rapid turnover 
(Top panel) FLAG-tagged EDEM1-ΔIDR(N)/(C) and MLD  were transfected into 
HEK293T. Proteins were radiolabeled for 30 min with [35S]-Cys/Met, and cells were 
lysed in MNT buffer. Time points were collected at 0, 2, and 4 hr after the pulse. Proteins 
were resolved on reducing 8% SDS-PAGE. (Bottom panel) The amount of EDEM1 
protein remaining at 2 hr and 4 hr was quantified and normalized to the starting material 
(0 h) and averaged from three independent experiments. Statistical significance between 
MLD, EDEM1-ΔIDR (N) or (C) and EDEM1 (FL) at 4 hr was determined by an unpaired 
t-test, the measurement designated (**) has a p value of 0.005, and that of (*) is 0.012. 
Error bars represent mean ±S.E. 
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Figure 3.11 EDEM1 IDRs are required for the ERdj5 association 
FLAG-tagged EDEM1 (FL), EDEM1-ΔIDR(N), EDEM1-ΔIDR(C), MLD-FLAG, and 
empty plasmid (mock) were co-expressed with ERdj5-MYC in HEK293T cells. Cells 
were lysed in HBS buffer containing CHAPS. 10% of the lysate was collected for whole 
cell lysate (WCL), 40% for anti-FLAG and anti-MYC immunoprecipitation. Proteins 
were resolved on 8% reducing SDS-PAGE and immunoblotted against MYC, FLAG, and 
glucosidase II (GlucII). Gels are representative of three independent experiments. 
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Figure 3.12 EDEM2 exhibits thiol-dependent binding to Z/NHK and exposes 
reactive thiols 
(A) EDEM2-FLAG was co-expressed with WT A1AT, Z, Z C256S, NHK, NHK C256S, 
NHK NOG, and NHK NOG C256S in HEK293T cells. Cells were readiolabeled with  
[35S]-Cys/Met for 30 min and chased for 1 hr. Cells were lysed in MNT buffer 
containing Triton X-100. EDEM2 and A1AT variants were isolated using anti-FLAG and 
anti-A1AT immunoprecipitations, respectively. Proteins were resolved on 9% reducing 
SDS-PAGE. Asterisks denote background bands. (B) (Right panel) EDEM2-FLAG was 
expressed in HEK293T cells. Cells were pretreated with DTT (5 mM) where indicated 
(+/-). Cells were lysed in sample buffer containing 5 mM peg-maleimide (+ PEG-
Maleimide) or 20 mM NEM (- PEG-Maleimide). Proteins were resolved on 8.5% SDS-
PAGE and immunoblotted with FLAG antibody. (Left panel) Cartoon representation of 
EDEM2 Depicting signal peptide (green), MLD (cyan), Putative catalytic residues (red), 
Cys residues (yellow), predicted disulfides (*), and predicted IDRs (Red dashed box). 
Gels are representative of three independent experiments. 
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Figure 3.13 EDEM3 exhibits thiol-dependent binding to Z/NHK and exposes 
reactive thiols 
(A) EDEM3-FLAG was co-expressed with WT A1AT, Z, Z C256S, NHK, NHK C256S, 
NHK NOG, and NHK NOG C256S in HEK293T cells. Cells were readiolabeled with  
[35S]-Cys/Met for 30 min and chased for 1 hr. Cells were lysed in MNT buffer 
containing Triton X-100. EDEM2 and A1AT variants were isolated using anti-FLAG and 
anti-A1AT immunoprecipitations, respectively. Proteins were resolved on 9% reducing 
SDS-PAGE. Asterisks denote background bands. (B) (Right panel) EDEM3-FLAG was 
expressed in HEK293T cells. Cells were pretreated with DTT (5 mM) where indicated 
(+/-). Cells were lysed in sample buffer containing 5 mM peg-maleimide (+ PEG-
Maleimide) or 20 mM NEM (- PEG-Maleimide). Proteins were resolved on 8.5% SDS-
PAGE and immunoblotted with FLAG antibody. (Left panel) Cartoon representation of 
EDEM3 depicting signal peptide (green), MLD (cyan), protease-associated domain 
(purple), putative catalytic residues (red), Cys residues (yellow), predicted disulfides (*), 
and predicted IDRs (Red dashed box). Gels are representative of three independent 
experiments. 
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Figure 3.14 Structural model of the human EDEM1 MLD exhibits surface-
exposed hydrophobic patches  
(Left) Front view of the MLD surface model (Phyre 2.0) (1) depicting three putative 
catalytic residues (red), Cys residues (yellow), and hydrophobic residues (orange), and 
Cys residue (yellow). (Right) Back view. 
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Figure 3.15 A1AT Cys256 is partially buried 
(Left) Ribbon representation of A1AT (PDB: 3DRM) depicting three glycosylation sites 
(green) and Cys256 (yellow). (Right) Surface model of A1AT showing partially buried 
Cys256 (arrow). 
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
The ER is a complex organelle that copes with constant stresses due to an influx 
of nascent polypeptides, which it must process and sort in a crowded environment, all the 
while avoiding aggregation of misfolded proteins and maintaining proper protein 
homeostasis. As such, a network of regulated quality control components has evolved to 
serve as a system of checks and balances to promote protein folding and facilitate 
degradation. This system is centered around core chaperone proteins, each functioning in 
distinct ways that act on a variety of substrates ranging from fast folding proteins to slow 
folding bulky proteins that require multimeric assembly.  
A subset of this quality control machinery is specialized in folding, repairing and 
sorting glycoproteins. Determining the role of EDEM1 in ERAD has been an area of 
interest and goal for many groups. As more research has been conducted on ERQC 
ERAD and over the past two decades on EDEM1, we are beginning to uncover EDEM1’s 
unique modes of interaction and its overall function in ERAD. We have demonstrated 
that EDEM1 exhibits redox-sensitive substrate-binding properties as well as weak 
protein-protein interactions; further expanding our understanding of the many ways 
EDEM1 binds its partners. Additionally, we showed that both IDRs, which are 
responsible for the fast turnover rate of EDEM1, are required for ERdj5 binding but 
neither was required for NHK binding. Lastly, we demonstrated that the ability to 
preferentially interact with ERAD substrates and the redox-sensitive binding is an 
intrinsic property of the MLD.  
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Determining the oxidative state of EDEM1 and the implications of the redox-
sensitive binding 
Using detergents of varying strengths and in the presence of the reducing agent 
DTT, EDEM1 was found to bind NHK and Z through covalent and weak interactions 
(Figure 3.1).  The covalent interactions were mediated through the single Cys residue on 
NHK and Z (Figure 3.2). Although the Cys residue has previously been implicated in the 
ER retention and secretion of Z, this is the first time it has been reported to mediate 
binding to EDEM1 and the first time that a Cys-dependent substrate-binding requirement 
has been demonstrated for EDEM1.   
Many of the known ERAD clients possess Cys residues and some possess 
unpaired Cys. Like the WT α1-antitrypsin and the ERAD variants, WT transthyretin 
(TTR) and the ERAD substrate TTR (D18G) possess a single Cys residue that, for the 
WT, is required for stabilizing the TTR tetramer (Kingsbury et al., 2008). BASE457 is 
proposed to possesses unpaired Cys residues as suggested by aggregate formation upon 
treatment with the oxidizing agent diamide (Molinari et al., 2002). While the ERAD-
targeted ribophorin 1 (332) possesses no Cys. It would be of interest to see whether the 
Cys residues on these, particularly BACE457 as its interaction with EDEM1 has been 
established, and other ERAD clients, are involved in binding to EDEM family proteins. 
Furthermore, it would be interesting to see whether incorporating a Cys residue on TTR 
(D18G), which is not a known EDEM1 client, would promote its recognition by EDEM1. 
Another experiment of interest is to strategically incorporate Cys residues, in such a way 
that aberrant dimers are not formed, onto properly folded mature proteins like A1AT.  
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We demonstrated that NHK lacking all three of its glycans (NOG) and possessing 
the Cys256Ser mutation no longer interacted with EDEM1, while NHK NOG possessing 
Cys256 did interact (data not shown). Since the glycans are not present on NHK NOG, 
thus do not mediate an interaction with EDEM1, and the only difference between the two 
proteins is the presence of Cys256, it would of interest to use this this protein to 
determine whether EDEM1 recognizes other regions on NHK, such as exposed 
hydrophobic regions, or whether this interaction is mediated through auxiliary ERAD 
machinery proteins that do not bind WT A1AT.   
A cell-based assay was utilized to identify reactive thiols on EDEM1 using 
maleimide modification revealed that a subset of the Cys on EDEM1 is unpaired and 
accessible to maleimide labeling, and a subset is involved in disulfides or inaccessible to 
modification (Figure 3.3). The purpose of this assay served as a first step in determining 
whether the Cys on EDEM1 were directly involved in the redox-sensitive interaction with 
NHK and Z.  Although the cell-based maleimide modification technique used in this 
study is appropriate for revealing reactive thiols, the technique has a few shortcomings 
especially in terms of determining a disulfide map. For example, the Cys residues that 
were not accessible to maleimide modification can only be conclusively identified as 
being involved in disulfides, which encompasses potential disulfides within EDEM1 as 
well as disulfides between EDEM1 and another protein like an oxidoreductase.  
A technique such as mass spectrometry would be better suited for determining the 
disulfide map of EDEM1. Attempts to identify the EDEM1 disulfide map using mass 
spectrometry and differential alkylation methods proved challenging. EDEM1 expressed 
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in mammalian cells in a large-scale setting and isolated through immunoprecipitation was 
subjected to differential alkylation using N-ethylmaleimide (NEM) and deuterium-
labeled N-ethylmaleimide in a recent collaborative effort (data not shown) and uncovered 
a few issues. First, obtaining adequate amounts of EDEM1 from HEK293T cells through 
FLAG immunoprecipitation proved challenging, and with each optimization attempts 
yielding low amounts of EDEM1. Instead, performing affinity column purification or 
expressing EDEM1 in cells that are more suitable to handle the stresses of EDEM1 
overexpression, for instance pancreatic cell lines, would be preferable.  
Second, although steps were carried out to label reactive thiols with NEM and any 
paired Cys with deuterium-labeled NEM, post reduction, it appears that each Cys is 
involved in forming disulfides to a certain degree, as monitored by NEM: deuterium-
labeled NEM ratios. These disulfides are either intermediate disulfides or indicative that 
the native disulfides on EDEM1 are dynamic, which is difficult to determine using the 
current method. Furthermore, using this method yielded all Cys except for two as 
enzymatic cleavage was incomplete.  To accurately determine a disulfide map for 
EDEM1 and identify the Cys that are unpaired, future work should employ techniques to 
trap peptides linked through disulfide bonds, differentiate intra- from intermolecular 
disulfides and acquiring purified, natively folded EDEM1 to help resolve issues of 
trapping non-native intermediate disulfides.  
Through a series of Cys to Ser single or combinational point mutations, we 
determined that not a single Cys is solely responsible for the interaction with NHK 
through Cys256 nor are the predicted unpaired Cys. Instead, it appears that at least one 
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set of the predicted disulfides is necessary for this interaction. How this redox-sensitive 
binding is mediated remains undetermined. Since an EDEM1-NHK dimer is not 
observable (data not shown), it is likely that the redox-sensitive binding is mediated 
through an oxidoreductase. Shedding light on this possible mode of interaction could be 
achieved by employing mass spectrometry in combination with Cys mutations to identify 
the EDEM1 binding partners under oxidative and reducing conditions.  Preliminary data 
using sucrose sedimentation of the EDEM1 MLD revealed a difference in complex sizes 
when comparing MLD under oxidative vs. reducing conditions (Figure 4.1). Further 
experimentation is required to understand the nature of these complexes.   
It remains possible that the reason an EDEM1-NHK is not readily observable 
because EDEM1 exists in a multi-protein complex, as observed from the presence of 
higher molecular weight species, thus a shift created from a single NHK monomer is not 
be substantial. Further experiments are required to identify the components of these high 
molecular weight species. Furthermore, it remains unknown whether EDEM1 or EDEM2 
and EDEM3, recognize and accelerate the degradation of monomeric NHK and Z or the 
aberrant dimers that are not present in WT A1AT.  Since these aberrant dimers are 
formed through Cys256 it is likely that the observed oxidation-sensitivity is a result of the 
dimer formation, however sorting this out will require careful analysis.  
It was recently determined that the oxidoreductase ERp46, through its active Cys-
Xxx-Xxx-Cys domain covalently binds to EDEM3 and that Cys83 and Cys441 on 
EDEM3 confer mannosidase activity of its MLD, as determined by in vitro studies (Yu et 
al., 2018). The EDEM3 Cys83/441 predicted disulfide is homologous to that of EDEM1 
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Cys160/529. This predicted disulfide is also conserved on EDEM2. Since our data 
indicate that either of the two predicted disulfides is required for binding to NHK, a 
follow up experiment would be to determine whether like EDEM3, these predicted 
disulfides, specifically Cys160/529, are required for MLD function by monitoring the 
degradation of NHK. A more direct approach is to use purified components and testing 
the in vitro mannosidase activity of EDEM1 MLD Cys-less, MLD possessing only 
Cys160/529, or only Cys410/457.   
In addition to possessing Cys83/441, EDEM3 possess two more Cys that are 
separated by two amino acids, thus resembling the Cys-Xxx-Xxx-Cys motif of 
oxidoreductase (Figure 3.13).  Although it is not predicted to structurally resemble a 
thioredoxin domain, as it is located within the EDEM3 MLD, it would be interesting to 
see whether that apparent Cys-Xxx-Xxx-Cys motif contributes to the observed redox-
sensitive interaction with NHK and Z.   
Defining the glycan branch selectivity of EDEM proteins  
The catalytic activity of the EDEM1 MLD was determined through 
overexpression of MLD and MLD (3K) with NHK and monitoring the glycan trimming 
on NHK through gel mobility shifts (Figure 3.9). Although we confirmed the MLD 
catalytic activity, the branch specificity on which the MLD acts is another source of 
uncertainty and will require further investigation.    
The EDEM1 MLD is homologous to that of α1-2 mannosidases, which act on α1-
2-linked mannoses. These mannoses are located on the terminal ends of the B- and C-
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branches and the entire A-branch of N-linked glycans of proteins localized in the ER 
(Figure 1.2). Since there are three EDEM1 homologs and MAN1B1 in the mammalian 
ER, it is unclear whether these proteins act separately on individual branches or if they 
are not branch-specific but rather α1-2-linked mannose specific. Determining the branch-
specificity of EDEM1 in vivo can be addressed using a variety of gene manipulation 
techniques and knockout cell lines.  
Since the A-branch is critical for CNX/CRT binding, whether or not EDEM1 acts 
on this branch can be determined through a reglucosylation assay that is well established 
and routinely used in our lab (Pearse and Hebert, 2010; Tannous et al., 2015a). The 
mutant Chinese hamster ovary cell line, MI8-5, transfers unglucosylated (Man9GlcNac2) 
N-linked glycans, which can then acquire a single glucose moiety on the terminal 
mannose of the A-branch through the activity of UDP-Glc:glycoprotein 
glucosyltransferase 1 (UGT1) (Hebert et al., 1995). Levels of A-branch reglucosylation 
can be monitored by inhibiting glucosidase II (Figure 1.3), which removes the glucose 
moiety added on by UGT1, and subjecting the lysates to affinity pull-down using GST-
calreticulin. If EDEM1 acts on the A-branch, then more reglucosylated ERAD substrates 
will accumulate upon knockout of EDEM1/MLD or EDEM1/MLD (3K).  Conversely, 
lower levels of reglucosylation will be observed in cells overexpressing EDEM1. We 
have obtained preliminary evidence that a mannosidase may be responsible for extracting 
substrates from calnexin/calreticulin folding cycles in these cell lines, as mannosidase 
inhibition through KIF or DMJ resulted in increased reglucosylation (Tannous, 2015). 
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Since the MI8-5 cell line is derived from mutant hamster cell lines, acquiring the 
nucleotide sequence of the EDEM1gene-for RNAi purposes may be challenging; 
therefore it would be ideal to perform these experiments in human cells. We have just 
acquired CRISPR/Cas9 knocked out alg6 HEK293 cell that we still need to verify 
(Figure 4.2). Human cell-line that transfers glycans composed solely of the A-branch 
through ALG3/ALG12 can be generated through CRISPR/Cas9 knockout. These mutant 
cell-lines can then be used to monitor reglucosylation upon EDEM1 overexpression or 
knockdown, as well as look at mannose trimming through gel mobility shifts to see if 
EDEM1 acts on the A-branch.  
Whether EDEM1 acts on the B-branch can be addressed by creating ALG12 
knockout cells, which will transfer N-linked glycans lacking the C-branch. Determining 
whether Man6 glycoforms accumulate in cells overexpressing EDEM1, can be addressed 
using a pull-down assay using Os9 or Yos9p, or through HPLC mediated glycomics.  
Similarly, whether EDEM1 acts on the C-branch can be determined via ALG3 
knockout cells, which will transfer N-linked glycans lacking the B-branch. The effects of 
EDEM1 on the C-branch can be addressed using a GST-fusion with the OS-9 mannose-6-
phosphate receptor homology domain (GST- OS9MRH), since OS-9 possesses high 
affinity to glycans exposing the C-branch α1,6-linked mannose (Hosokawa et al., 2009).  
Lastly, since ALG12/ALG9 knockout will generate glycoforms lacking the 
terminal mannose on the C-branch we can then determine whether this mutation bypasses 
the need for EDEM1 by monitoring if substrates still get targeted for degradation in the 
absence of EDEM1 (ex. EDEM1 CRISPR/Cas9 knockout). If not, it possible that that 
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EDEM1 is required to act on the A-branch or that it also functions as a lectin that 
recognizes the α1-6-linked mannoses to target the ERAD substrate for degradation.  
Determining whether the EDEM1 or the MLD preferentially binds untrimmed 
glycoforms on ERAD machinery such as SEL1L or on ERAD targeted misfolded 
substrates can also be accomplished using the cell lines MadIA214 which transfer 
Glc1Man5GlcNAc2 en bloc and the B3F7 which transfer Glc3Man5GlcNAc2 en bloc 
(Ermonval et al., 2001; Stoll et al., 1988; Foulquier et al., 2004). Although these hamster 
cell-lines have been previously used for ERAD studies, it is not clear that ERAD is 
functional, as every glycoprotein, including ERAD machinery, would appear to exhibit 
extensively demannosylated glycans which are thought to be signals for degradation. 
Lastly, genomic editing can also be utilized to create human cell lines depleted of 
EDEM2 and EDEM3, individually or in combination, as has been done in chicken cell 
lines (Ninagawa et al., 2015). Glycans from these cell lines can be subjected to glycomics 
to identify the most abundant glycoform from each condition.  
Determining the substrate binding properties and characteristics of endogenous 
EDEM1 
Our research has further expanded our knowledge on EDEM1 and its ability to 
use different binding modalities to interact with substrates or machinery. We also 
demonstrated mannosidase activity of the EDEM1 MLD. However these conclusions are 
derived from studies in which EDEM1 is overexpressed, as such they may promote 
binding and glycan trimming due to the increase in local EDEM1 concentration. This is 
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especially true when considering that the relative abundance of EDEM1 in mammalian 
cell is low until it is upregulated by the unfolded protein response. Thus, in order to fine-
tune the precise role of EDEM1 in ERAD and ERQC, it is important to study the function 
and properties of endogenously expressed EDEM1.  
Since commercially available antibodies of EDEM1 do not appear specific, as 
those that we tested either appear to recognize a non-glycosylated protein (~75kD) that 
does not shift upon treatment with PNGaseF treatment, do not recognize the 
overexpressed EDEM1, or the protein that is recognized does not appear upregulated by 
ER-stress. Ideally, monoclonal antibodies with a strong specificity toward EDEM1 
should be carefully and strategically generated in order to better study endogenous 
EDEM1. Since generating antibodies is a time consuming and difficult task that does not 
guarantee positive results, a more streamlined way to study the binding properties and 
catalytic activity of EDEM1 is by introducing a C-terminal tag on the endogenous loci 
using CRISPR/Cas9.  
Another unanswered question is how are the soluble MLD and ΔIDR constructs 
retained in the ER? Full-length EDEM1 exhibits dual topology and exists as a soluble and 
membrane-bound substrate (Tamura et al., 2011). A preliminary experiment 
demonstrated that all constructs, which possess the same signal peptide/transmembrane 
segment as full-length EDEM1, also exhibit dual topology (Figure 4.3). Hence, the ER 
retention of soluble EDEM1 is inherent to the MLD and possibly mediated through 
binding to auxiliary proteins; however, which protein and how this is mediated has not 
yet been determined. This can be addressed through gene silencing, or conditional 
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silencing, of EDEM1 ER-resident binding partners and monitoring the localization of 
EDEM1.   
Lastly it is not clear if the EDEM1 IDR regions possess machinery-binding 
properties on their own. Expressing tagged versions of these construct and testing their 
ability to bind ERdj5 is one way to address this issue. Additionally, these regions could 
be used as baits to trap and identify EDEM1 binding partners through mass spectrometry. 
However, these experiments may be problematic as it is likely that the disordered regions 
could bind proteins non-specifically. 
Summary 
 In this study, we have identified a novel redox-sensitive binding modality on 
EDEM1, which is employed in the interaction with the ERAD substrates NHK and Z. 
Specifically, the interaction exhibits characteristics of a covalent interaction and is 
mediated through the lone Cys residue on NHK. We demonstrated that EDEM1 possess 
reactive thiols at steady state. However, none of these unpaired Cys are involved in the 
interaction with NHK/Z. Instead, the Cys that are likely paired appeared involved and 
possibly through an oxidoreductase other than ERjd5. Future work is required to 
determine the identity of this oxidoreductase.  
In addition to the redox-sensitive binding, we also show that the interaction 
between EDEM1 and NHK/Z involves weak protein-protein interactions of an 
undetermined nature. We have confirmed the presence of two intrinsically disordered 
regions on EDEM1. Both disordered regions are required for maintaining the interaction 
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with ERdj5. The intrinsic disordered properties of the IDRs contribute to the short half-
life of EDEM1.   
Lastly, we successfully expressed and characterized the EDEM1 mannosidase-
like domain (MLD) in mammalian cells. The MLD not only promotes glycan trimming 
on NHK, but also exhibits the same redox-sensitive substrate binding properties as that of 
the full-length protein. Moreover, showing that the MLD alone retains all the substrate 
binding and catalytic characteristics of EDEM1 sets the stage for future work for 
examining the biophysical properties of the functional MLD in vitro, as attempts to do so 
in the past with the full length protein have proven unsuccessful.    
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Figure 4.1 EDEM1 MLD sedimentation differs upon addition of DTT   
HEK293T cells were transfected with FLAG-tagged EDEM1 MLD and incubated for 48 
hr. DTT (5mM) was added for 1 hr prior to lysis. Cells were lysed in MNT buffer, and 
samples were layered on top of a continuous 10-40 % sucrose gradient in MNT buffer 
prior to ultracentrifugation. Fractions were collected from the top of the gradient, and 
proteins were precipitated with trichloroacetic acid. Proteins were resolved on 8.5% SDS-
PAGE and immunoblotted against FLAG.  
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Figure 4.2 Partial schematic of mammalian genes (ALG) responsible for the 
biosynthesis of the B- and C-branches of ER glycans.  
The Man5GlcNAc2 structure is synthesized on a dolichol group (black rectangle). Left to 
right, ALG3 and ALG9 synthesize the B-branch while ALG12 and ALG9 create the C-
branch.  ALG6, ALG8, and ALG10 are responsible for adding on the three glucoses (blue 
circles) to the terminal mannose (green circles) on the A-branch. Red α1,6 linkages 
denote mannoses recognized by the Os9/Yos9p and XTP3B lectins.  
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Figure 4.3 EDEM1 FL, ΔIDR (N), ΔIDR (C) and MLD exhibit dual topology and 
are found in membrane and soluble fractions.       
HEK293T cells expressing FLAG-tagged EDEM1 FL, ΔIDR(N), ΔIDR(C) and MLD 
were homogenized, fractionated and subjected to alkaline extraction. The fractions 
collected were whole cell lysate (WCL), nucleus (N), cytosol (C), total membrane (TM), 
as well as supernatant (S) and pellet (P) fractions upon alkaline extraction of the TM. 
Samples were resolved by reducing 8.5% SDS-PAGE. Asterisks denote non-specific 
bands.  
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